<SEC-DOCUMENT>0001213900-23-040663.txt : 20230517
<SEC-HEADER>0001213900-23-040663.hdr.sgml : 20230517
<ACCEPTANCE-DATETIME>20230517092010
ACCESSION NUMBER:		0001213900-23-040663
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230516
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230517
DATE AS OF CHANGE:		20230517

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GD Culture Group Ltd
		CENTRAL INDEX KEY:			0001641398
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-METALS, MINERALS (NO PETROLEUM) [5050]
		IRS NUMBER:				473709051
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37513
		FILM NUMBER:		23929812

	BUSINESS ADDRESS:	
		STREET 1:		FLAT 1512, 15F, LUCKY CENTRE
		STREET 2:		NO.165-171 WAN CHAI ROA
		CITY:			WAN CHAI
		STATE:			K3
		ZIP:			000000
		BUSINESS PHONE:		852-95791074

	MAIL ADDRESS:	
		STREET 1:		FLAT 1512, 15F, LUCKY CENTRE
		STREET 2:		NO.165-171 WAN CHAI ROA
		CITY:			WAN CHAI
		STATE:			K3
		ZIP:			000000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Code Chain New Continent Ltd
		DATE OF NAME CHANGE:	20200518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TMSR HOLDING Co Ltd
		DATE OF NAME CHANGE:	20180207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JM Global Holding Co
		DATE OF NAME CHANGE:	20150505
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea178802-8k_gdculture.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:GDC="http://ccnctech.com/20230516">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_GDC_ccnctech.com_20230516 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20230516_20230516 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001641398 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityAddressPostalZipCode_00000 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityCentralIndexKey">0001641398</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityAddressPostalZipCode">00000</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gdc-20230516.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-16to2023-05-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001641398</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-16</xbrli:startDate>
        <xbrli:endDate>2023-05-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20230516__20230516_z85FjnjxHVq7"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):&#160;<span id="xdx_909_edei--DocumentPeriodEndDate_c20230516__20230516_zTm8UkxWGh9i"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May
16, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20230516__20230516_zgTw92nsfKIk"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityRegistrantName">GD Culture Group Limited</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of Company as specified in charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20230516__20230516_zOe8PukzGwTh"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityFileNumber_c20230516__20230516_zmKM6BsaXq7k"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityFileNumber">001-37513</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20230516__20230516_ztELA3fDTwAi"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityTaxIdentificationNumber">47-3709051</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State or other jurisdiction&#160;<br />
of incorporation)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission File No.)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS Employer</b><br />
<b>Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20230516__20230516_zAAnfRSmLBsb"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityAddressAddressLine1">c/o GD Culture Group Limited</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine2_c20230516__20230516_zDiOp6Z5xYPg"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityAddressAddressLine2">Flat 1512, 15F, Lucky Centre,</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_907_edei--EntityAddressAddressLine3_c20230516__20230516_zIPEl8kqTGDc"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityAddressAddressLine3">No.165-171 Wan Chai Road</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_903_edei--EntityAddressCityOrTown_c20230516__20230516_zarje9g9NC94"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:EntityAddressCityOrTown">Wan Chai</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCountry_c20230516__20230516_zKjdIsN8OwBe"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Hong Kong</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of Principal Executive Offices) (Zip
code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_908_edei--CityAreaCode_c20230516__20230516_zdfeOhfHc7X"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:CityAreaCode">+852</ix:nonNumeric></span>-<span id="xdx_90D_edei--LocalPhoneNumber_c20230516__20230516_zrHzu0hskONb"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:LocalPhoneNumber">95791074</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Company&#8217;s Telephone number, including
area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions (see General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20230516__20230516_zF3wukNZNFlk"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--SolicitingMaterial_c20230516__20230516_zKx9FwPGCU3k"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--PreCommencementTenderOffer_c20230516__20230516_zXTtkonFSXph"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20230516__20230516_zP9wb6iqQcbc"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#160;<span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20230516__20230516_znCrz9vvvYq3"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20230516__20230516_zGfKQ2PQe6yl"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:Security12bTitle">Common Stock, par value $0.0001</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20230516__20230516_z8DHcEap7aui"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" name="dei:TradingSymbol">GDC</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SecurityExchangeName_c20230516__20230516_zYPTTM5glWNe"><ix:nonNumeric contextRef="From2023-05-16to2023-05-16" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously reported, on May 1, 2023, GD Culture
Group Limited (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;RD Securities Purchase Agreement&#8221;),
pursuant to which the Company sold an aggregate of 310,168 shares of common stock (the &#8220;Common Shares&#8221;) of the Company, par
value $0.0001 per share, and pre-funded warrants to purchase up to an aggregate of 844,351 shares of common stock (the &#8220;Pre-Funded
Warrants&#8221;, and the common stock underlying such warrants, the &#8220;Pre-Funded Warrant Shares&#8221;) to certain purchasers (the
&#8220;Purchasers&#8221;) (the &#8220;RD Offering&#8221;). The purchase price of each Common Share was $8.27. The purchase price of each
Pre-funded Warrant was $8.269, which equals the price per Common Share being sold to the public in the RD Offering, minus $0.001. The
RD Offering was being made pursuant to a shelf registration statement (No.&#160;333-254366)&#160;on Form&#160;S-3,&#160;which was declared
effective by the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 26, 2021, and related prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a concurrent private placement, the Company
entered into a private warrant securities purchase agreement (the &#8220;PIPE Securities Purchase Agreement&#8221;), pursuant to which
the Company sold warrants to purchase up to 1,154,519 shares of common stock (the &#8220;Unregistered Warrants&#8221;, and the common
stock underlying such warrants, the &#8220;Unregistered Warrant Shares&#8221;) to the Purchasers (the &#8220;PIPE Offering&#8221;, together
with the RD Offering, collectively the &#8220;Offering&#8221;). Unregistered Warrants were exercisable at $8.27 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company entered into a placement
agency agreement (the &#8220;Placement Agency Agreement&#8221;), with Univest Securities, LLC, acting as the placement agent of the Offering
(the &#8220;Placement Agent&#8221; or &#8220;Univest&#8221;). Pursuant to the Placement Agency Agreement, the Company issued warrants
to the Placement Agent to purchase up to 115,452 shares of Common Stock (equal to 5.0% of the aggregate number of Common Shares, Pre-Funded
Warrant Shares, and the Unregistered Warrant Shares) at an exercise price of $9.924 per share, which represents 120% of the offering price
of each share (the &#8220;Placement Agent Warrants&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Amendment</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 16, 2023, the Company entered into an amendment
to the RD Securities Purchase Agreement with the Purchasers, pursuant to which the purchase price of each Common Share was increased to
$8.35 and the purchase price of each Pre-funded Warrant was increased to $8.349.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Concurrently, the Company entered into an amendment
to the PIPE Securities Purchase Agreement with the Purchasers, pursuant to which the exercise price of each Unregistered Warrant was increased
to $8.35 per share of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will receive net proceeds of
$84,972.60, after deducting placement agent&#8217;s 7% cash fee and 1% non-accountable expense allowance, as a result of such
amendments. The Company plans to use the net proceeds for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, as a result of such amendments and
pursuant to the Placement Agency Agreement, the Company amended and restated the Placement Agent Warrants to increase the exercise price
to $10.02 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The form of amendment to the RD Securities Purchase
Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. The form of amendment to
the PIPE Securities Purchase Agreement is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference.
The form of amended and restated Unregistered Warrants is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated
herein by reference. The form of Placement Agent&#8217;s Warrants is filed as Exhibit 4.2 to this Current Report on Form 8-K and is incorporated
herein by reference. The foregoing descriptions of the terms of the amendment to the RD Securities Purchase Agreement, the amendment to
the PIPE Securities Purchase Agreement, the form of amended and restated Unregistered Warrants and the form of Placement Agency Agreement
do not purport to be complete descriptions of the rights and obligations thereunder and are qualified in their entirety by reference to
such exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
Number</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea178802ex4-1_gdculture.htm">Form of Unregistered Warrants</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea178802ex4-2_gdculture.htm">Form of Placement Agent Warrants</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea178802ex10-1_gdculture.htm">Form of Amendment to RD Securities Purchase Agreement between the Company and certain Purchasers, dated May 16, 2023</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea178802ex10-2_gdculture.htm">Form of Amendment to PIPE Securities Purchase Agreement between the Company and certain Purchasers, dated May 16, 2023</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GD CULTURE GROUP LIMITED</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: May 17, 2023</span></td>
    <td style="width: 5%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Xiaojian Wang</i></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaojian Wang</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, President and<br />
Chairman of the Board</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">2</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: left; margin-top: 0; margin-bottom: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2Wsq1jPAyqYgsQiK6XXKMJd2R2e3HR+ot25RoGBiGc75zhAjFmla6RobzosjhiE1bK4dQYIWM5oLekW22Kfhb4FVbx8q4/v2BGXkGPZOM5Fx5obc+tMUyhSgZy9k4noCU6TSCw04EXz0jU+kSjdOqBmVKODC1rNEp7oaEo3qRoabrq07IVpNJQY6iQX5DHMkY9vRQT+KbhTzPRBD2E4g107391tytowaWNTa+yw7of4MPGhxJTA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea178802ex4-1_gdculture.htm
<DESCRIPTION>FORM OF UNREGISTERED WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">NEITHER THIS SECURITY
NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE u.s. SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES
ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">Amended and restated</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">COMMON STOCK PURCHASE
WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date of Issuance: May [&#9679;], 2023 (&ldquo;<B>Issuance Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">GD Culture Group Limited,
a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, [&#9679;], the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;),
is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Common Stock Purchase Warrant (including any Common Stock Purchase Warrants issued in exchange, transfer or replacement
hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time,
on the Expiration Date (as defined below), up to [&#9679;] (subject to adjustment as provided herein) shares of common stock of the Company,
par value $0.0001 (the &ldquo;<B>Common Stock</B>&rdquo;) (as subject to adjustment hereunder, the &ldquo;<B>Warrant Shares</B>&rdquo;).
Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 17. This Warrant is
issued to Holder pursuant to that certain Securities Purchase Agreement, effective as of May [&#9679;], 2023, as amended, by and between
the Company and the Holder (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">1.
<U>EXERCISE OF WARRANT</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(a)&nbsp;<U>Mechanics of
Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(f)),
this Warrant may be exercised by the Holder on any day on or after the Issuance Date in whole or in part, by delivery (whether via
facsimile or otherwise) of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise
Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day following an exercise of
this Warrant as aforesaid, the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the
date of such exercise multiplied by the number of Warrant Shares as to which this Warrant was so exercised (in respect of such
specific exercise, the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;) in cash or via wire transfer of immediately available funds if
the Holder did not notify the Company in such Exercise Notice that such exercise was made pursuant to a Cashless Exercise (as
defined in Section 1(d)). The Holder shall not be required to deliver the original of this Warrant in order to effect an exercise
hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the Warrant Shares shall have the same
effect as cancellation of the original of this Warrant certificate and issuance of a new Warrant certificate evidencing the right to
purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining Warrant
Shares shall have the same effect as cancellation of the original of this Warrant certificate after delivery of the Warrant Shares
in accordance with the terms hereof. On or before the first (1st) Trading Day following the date on which the Company has received
an Exercise Notice, the Company shall transmit by facsimile or e-mail an acknowledgment of confirmation of receipt of such Exercise
Notice, in the form attached hereto as <B><U>Exhibit B</U></B>, to the Holder and the Company&rsquo;s transfer agent (the
&ldquo;<B>Transfer Agent</B>&rdquo;). On or before the second (2nd) Trading Day following the date on which the Company has received
such Exercise Notice (the &ldquo;<B>Required Delivery Date</B>&rdquo;), the Company shall (i) provided that the Transfer Agent is
participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program (which the
Company shall cause the Transfer Agent to do at Holder&rsquo;s request), upon the request of the Holder, credit such aggregate
number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its
designee&rsquo;s balance account with DTC through its Deposit or Withdrawal at Custodian system, or (ii) if the Transfer Agent is
not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver to the Holder or, at the Holder&rsquo;s
instruction pursuant to the Exercise Notice, the Holder&rsquo;s agent or designee, in each case, sent by reputable overnight courier
to the address as specified in the applicable Exercise Notice, a certificate, registered in the Company&rsquo;s registrar in the
name of the Holder or its designee (as indicated in the applicable Exercise Notice), for the number of shares of the Common Stock to
which the Holder is entitled pursuant to such exercise. Upon delivery of an Exercise Notice, the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the
certificates evidencing such Warrant Shares (as the case may be). If this Warrant is submitted in connection with any exercise
pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant is greater than the number of Warrant
Shares being acquired upon an exercise, then, at the request of the Holder and upon surrender hereof by the Holder at the principal
office of the Company, the Company shall as soon as practicable and in no event later than three (3) Business Days after any
exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section 7(d))
representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant,
less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional shares of Common Stock or scrip
representing fractional shares of Common Stock shall be issued upon the exercise of this Warrant, but rather the number of shares of
Common Stock to be issued shall be rounded up to the nearest whole number. The Company shall pay any and all taxes and fees which
may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(b)&nbsp;<U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $8.35, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(c)&nbsp;<U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If the Company fails to issue and deliver (or cause to be delivered) to the Holder by the Required
Delivery Date a certificate representing the Warrant Shares or credit the balance account of Holder or Holder&rsquo;s nominee with DTC
for such number of Warrant Shares so delivered to the Company, then, in addition to all other remedies available to Holder, at the sole
discretion of Holder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;pay
in cash to Holder on each Trading Day after the Required Delivery Date that the issuance or credit of such Warrant Shares is not timely
effected an amount equal to 1% of the product of (A) the number of shares of Common Stock not so delivered or credited (as the case may
be) to Holder or Holder&rsquo;s nominee multiplied by (B) the Closing Sale Price of the Common Stock on the Trading Day immediately preceding
the Required Delivery Date; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">(A)&nbsp;if on or after the Required Delivery Date, Holder (or any other Person in respect, or on behalf, of Holder) purchases (in an open market
transaction or otherwise) Common Stock (&ldquo;<B>Replacement Common Stock</B>&rdquo;) to deliver in satisfaction of a sale by Holder
of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion
of the number of shares of Common Stock, that Holder so anticipated receiving from the Company without any restrictive legend, then, within
five (5) Trading Days after Holder&rsquo;s request and in Holder&rsquo;s sole discretion, either (A) pay cash to Holder in an amount equal
to Holder&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the Replacement
Common Stock (the &ldquo;Buy-In Price&rdquo;), at which point the Company&rsquo;s obligation to so deliver such certificate or credit
Holder&rsquo;s balance account shall terminate and such Common Stock shall be cancelled, or (B) promptly honor its obligation to so deliver
to Holder a certificate or certificates or credit Holder&rsquo;s DTC account representing such number of shares of Common Stock that would
have been so delivered if the Company timely complied with its obligations hereunder and pay cash to Holder in an amount equal to the
excess (if any) of the Buy-In Price over the product of (1) such number of shares of Common Stock that the Company was required to deliver
to Holder by the Required Delivery Date multiplied by (2) the lowest Closing Sale Price of the Common Stock on any Trading Day during
the period commencing on the date Holder purchased Replacement Common Stock and ending on the date of such delivery and payment under
this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent permitted by law, the Company&rsquo;s
obligations to issue and deliver the shares of Common Stock upon exercise of the Warrant in accordance with the terms hereof are absolute
and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any
provision hereof, the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by the Holder or any other person of any obligation to the Company or any violation
or alleged violation of law by the Holder or any other person, and irrespective of any other circumstance that might otherwise limit such
obligation of the Company to the Holder in connection with the issuance of the shares of Common Stock. Nothing herein shall limit the
Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver the shares of Common Stock
issuable upon exercise of this Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(d)&nbsp;<U>Cashless
Exercise</U>. The Holder may in its sole discretion (and without limiting the Holder&rsquo;s rights and remedies contained herein or in
any of the other Transaction Documents (as defined in the Securities Purchase Agreement)), exercise this Warrant in whole or in part and,
in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise
Price, elect instead to receive upon such exercise the &ldquo;Net Number&rdquo; of shares of Common Stock determined according to the
following formula (a &ldquo;<B>Cashless Exercise</B>&rdquo;):</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Net Number = (A x B) / C</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For purposes of the foregoing formulas:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">A=</TD><TD STYLE="text-align: justify">The total number of shares of Common Stock with respect to which this Warrant is then being exercised.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">B=</TD><TD STYLE="text-align: justify">The Black Scholes Value (as defined in Section 17 herein).</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">C=</TD><TD STYLE="text-align: justify">The Closing Bid Price of the Common Stock as of two (2) Trading Days prior to the time of such exercise (as such Closing Bid Price
is defined in Section 17 herein), but in any event not less than $0.01 (as may be adjusted for stock dividends, subdivisions, or combinations
in the manner described in Section 2(a) herein).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Warrant Shares are issued in such a cashless
exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take
on the characteristics of the Warrant being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the
holding period of this Warrant. Assuming (i) the Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions
of Rule 144 promulgated under the Securities Act with respect to Holder and the Warrant Shares are met in the case of such a cashless
exercise, the Company agrees that the Company will use its best efforts to cause the removal of the legend from such Warrant Shares (including
by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent at its own expense to ensure the foregoing),
and the Company agrees that the Holder is under no obligation to sell the Warrant Shares issuable upon the exercise of the Warrant prior
to removing the legend. The Company agrees not to take any position contrary to this Section 1(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(e)&nbsp;<U>Disputes</U>.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to
be issued pursuant to the terms hereof (including, without limitation, the Net Number), the Company shall promptly issue to the Holder
the number of Warrant Shares that are not disputed, provided that following such issuance to Holder such dispute shall be resolved in
accordance with Section 14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(f)&nbsp;<U>Limitations on
Exercises and Exchanges</U>. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable
or exchangeable by the Holder hereof to the extent (but only to the extent) that the Holder or any of its affiliates would beneficially
own in excess of 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common
Stock outstanding after giving effect to the issuance of shares of Common Stock underlying the Warrant issuable upon exercise of the
Warrants calculated in accordance with Section 13(d) of the 1934 Act (as defined in the Securities Purchase Agreement) (the &ldquo;<B>Maximum
Percentage</B>&rdquo;). To the extent the above</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">limitation applies, the determination of whether this Warrant shall be exercisable or exchangeable (vis-&agrave;-vis
other convertible, exercisable or exchangeable securities owned by the Holder or any of its affiliates) and of which such securities shall
be exercisable or exchangeable (as among all such securities owned by the Holder) shall, subject to such Maximum Percentage limitation,
be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior
inability to exercise or exchange this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability or exchangeability. For the purposes of this paragraph,
beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage
ownership) shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder.
The provisions of this paragraph shall be implemented in a manner otherwise than in strict conformity with the terms of this paragraph
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Maximum Percentage beneficial
ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such Maximum
Percentage limitation. The limitations contained in this paragraph shall apply to a successor Holder of this Warrant. The holders of Common
Stock shall be third party beneficiaries of this paragraph and the Company may not waive this paragraph without the consent of holders
of a majority of its Common Stock. For any reason at any time, upon the written or oral request of the Holder, the Company shall within
two (2) Business Days confirm orally and in writing to the Holder the number of Common Stock then outstanding, including by virtue of
any prior conversion or exercise or exchange of convertible or exercisable or exchangeable securities into Common Stock, including, without
limitation, pursuant to this Warrant or securities issued pursuant to the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(g)&nbsp;<U>Reservation
of shares of Common Stock; Insufficient Authorized share of Common Stock</U>. The Company shall initially reserve out of its authorized
and unissued shares of Common Stock a number of shares of Common Stock equal to 200% of the maximum number of shares of Common Stock underlying
the Warrant issuable to satisfy the Company&rsquo;s obligations to issue shares of Common Stock hereunder, and the Company shall at all
times keep reserved for issuance under this Warrant a number of shares of Common Stock equal to 200% of the maximum number of shares of
Common Stock underlying the Warrant issuable to satisfy the Company&rsquo;s obligation to issue shares of Common Stock hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(h)&nbsp;<U>[Reserved]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.&nbsp;<U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant
are subject to adjustment from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(a)&nbsp;<U>Stock
Dividends and Splits</U>. Without limiting any provision of Section 4, if the Company, at any time on or after the date of the Securities
Purchase Agreement, (i) pays a stock dividend on one or more classes of its then outstanding Common Stock or otherwise makes a distribution
on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any share split, stock dividend, recapitalization
or otherwise) one or more classes of its then outstanding</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Common Stock into a larger number of shares of Common Stock or (iii) combines
(by combination, reverse stock split or otherwise) one or more classes of its then outstanding Common Stock into a smaller number of shares
of Common Stock, then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number
of share of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common
Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant
to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.
If any event requiring an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then
the calculation of such Exercise Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(b)&nbsp;<U>Adjustment
Upon Issuance of Common Stock</U>. If, during the Restricted Period (as defined in the Securities Purchase Agreement), the Company effects
an Subsequent Financing (as defined in the Securities Purchase Agreement), or in accordance with this Section 2 is deemed to have effected
an Subsequent Financing, any shares of Common Stock (including the issuance or sale of Common Stock owned or held by or for the account
of the Company) issued or sold or deemed to have been issued or sold) for a consideration per share of Common Stock (the &ldquo;<B>New
Issuance Price</B>&rdquo;) less than a price equal to the Exercise Price in effect immediately prior to such issue or sale or deemed issuance
or sale (such Exercise Price then in effect is referred to as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive
Issuance</B>&rdquo;), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced (and in no event
increased) to the price per share of Common Stock as determined in accordance with the following formula:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">EP2 = EP1 x (A + B) / (A + C)</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><BR>
For purposes of the foregoing formula:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">A=</TD><TD STYLE="text-align: justify">The total number of Warrant Shares with respect to which this Warrant may be exercised.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">B=</TD><TD STYLE="text-align: justify">The total number of shares of Common Stock that would be issued or issuable under the Dilutive Issuance if issued at a per share of
Common Stock equal to EP1.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">C=</TD><TD STYLE="text-align: justify">The total number of shares of Common Stock actually issued or issuable under the Dilutive Issuance.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">EP1=</TD><TD STYLE="text-align: justify">The Exercise Price in effect immediately prior to a Dilutive Issuance.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">EP2=</TD><TD STYLE="text-align: justify">The Exercise Price immediately after such Dilutive Issuance; provided, however, that such price shall in no event be less than $0.01
per share of Common Stock (as may be adjusted for stock dividends, subdivisions, or combinations in the manner described in Section 2(a)
herein, the &ldquo;Floor Price&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">provided, that if such issuance or sale
(or deemed issuance or sale) was without consideration, then the Company shall be deemed to have received the Floor Price for each such
share of Common Stock so issued or deemed to be issued. For all purposes of the foregoing (including, without limitation, determining
the adjusted Exercise Price and consideration per share under this Section 2(c)), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Issuance
of Options</U>. If, during the Restricted Period, the Company in any manner grants or sells any Options and the lowest price per share
of Common Stock for which one share of Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange
of any Convertible Securities issuable upon exercise of any such Option is less than the Applicable Price, then such shares of Common
Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option
for such price per share of Common Stock. For purposes of this Section 2(c)(i), the &ldquo;lowest price per share of Common Stock for
which one share of Common Stock is issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible
Securities issuable upon exercise of any such Option&rdquo; shall be equal to (A) the sum of the lowest amounts of consideration (if any)
received or receivable by the Company with respect to any one share of Common Stock upon the granting or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option minus (B) the
sum of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option plus the value
of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except
as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock
or of such Convertible Securities upon the exercise of such Options or upon the actual issuance of such shares of Common Stock upon conversion,
exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Issuance
of Convertible Securities</U>. If, during the Restricted Period, the Company in any manner issues or sells any Convertible Securities
and the lowest price per share of Common Stock for which one share of Common Stock is issuable upon the conversion, exercise or exchange
thereof is less than the Applicable Price, then such shares of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the issuance or sale of such Convertible Securities for such price per share. For the purposes
of this Section 2(c)(ii), the &ldquo;lowest price per share of Common Stock for which one share of Common Stock is issuable upon the conversion,
exercise or exchange thereof&rdquo; shall be equal to (A) the sum of the lowest amounts of consideration (if any) received or receivable
by the Company with respect to one share of Common Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise
or exchange of such Convertible Security minus (B) the sum of all amounts paid or payable to the holder of such Convertible Security (or
any other Person) upon the issuance or sale of such Convertible Security plus the value of any other consideration received or receivable
by, or benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment
of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such
Convertible Securities, and if any such issue or sale of such Convertible Securities is made upon exercise of any Options for which adjustment
of this Warrant has been or is to be made pursuant to other provisions of this Section 2(c), except as contemplated below, no further
adjustment of the Exercise Price shall be made by reason of such issue or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Change
in Option Price or Rate of Conversion</U>. If, during the Restricted Period, the purchase or exercise price provided for in any Options,
the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate
at which any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases
at any time, the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would
have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes
of this Section 2(c)(iii), if the terms of any Option or Convertible Security that was outstanding as of the date of issuance of this
Warrant are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security
and shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the
date of such increase or decrease. No adjustment pursuant to this Section 2(c) shall be made if such adjustment would result in an increase
of the Exercise Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;<U>Calculation
of Consideration Received</U>. If, during the Restricted Period, any Option or Convertible Security is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company, together comprising one integrated transaction, (A) such Option
or Convertible Security (as applicable) will be deemed to have been issued for consideration equal to the Black Scholes Value &ndash;
Consideration thereof and the other securities issued shares of Common Stock, Options or Convertible Securities are issued or sold or
deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount of consideration
received by the Company therefor. If any Common Stock, Options or Convertible Securities are issued or sold for a consideration other
than cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration
consists of publicly traded securities, in which case the amount of consideration received by the Company for such securities will be
the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding the date of receipt.
If any Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger
in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion
of the net assets and business of the non-surviving entity as is attributable to such Common Stock, Options or Convertible Securities,
as the case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the
Company and the Holder. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring
valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such consideration will be determined within five (5) Trading
Days after the tenth (10th) day following such Valuation Event by an independent, reputable appraiser jointly selected by the Company
and the Holder. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and
expenses of such appraiser shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Record
Date</U>. If, during the Restricted Period, the Company takes a record of the holders of Common Stock for the purpose of entitling them
(A) to receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe
for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the
issue or sale of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution
or the date of the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(c)&nbsp;<U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a) or (b) of this Section 2, the
number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that
after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the
aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).
In addition, and notwithstanding anything to the contrary contained herein, upon a Cashless Exercise as set forth in Section 1(d) hereof,
the number of Warrant Shares for which this Warrant is exercisable immediately following such Cashless Exercise shall be equal to (i)
the number of Warrant Shares for which this Warrant was exercisable immediately prior to such Cashless Exercise <U>less</U> (ii) the number
of Warrant Shares as to which such Cashless Exercise was exercised (such number of Warrant Shares in this clause (ii) in respect of such
Cashless Exercise being equal to &ldquo;A&rdquo; in such Cashless Exercise formula in respect of such Cashless Exercise) and the number
of such Warrant Shares issuable hereunder shall automatically be adjusted, as necessary, to enable to the Company to comply with its obligations
to issue the Net Number of shares of Common Stock under Section 1(d)(i) hereof upon any Cashless Exercise thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(d)&nbsp;<U>Calculations</U>.
All calculations under this Section 2 shall be made by rounding to the nearest 1/10000<SUP>th</SUP> of cent and the nearest 1/100<SUP>th</SUP>
of a share of Common Stock, as applicable. The number of shares of Common Stock outstanding at any given time shall not include Common
Stock owned or held by or for the account of the Company, and the disposition of any such Common Stock shall be considered an issue or
sale of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(e)&nbsp;<U>Other
Events</U>. In the event that the Company shall take any action to which the provisions hereof are not strictly applicable, or, if applicable,
would not operate to protect the Holder from dilution or if any event occurs of the type contemplated by the provisions of this Section
2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom
stock rights or other rights with equity features), then the Company&rsquo;s board of directors shall in good faith determine and implement
an appropriate adjustment in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder,
provided that no such adjustment pursuant to this Section 2(e) will increase the Exercise Price or decrease the number of Warrant Shares
as otherwise determined pursuant to this Section 2, provided further that if the Holder does not accept such adjustments as appropriately
protecting its interests hereunder against such dilution, then the Company&rsquo;s board of directors and the Holder shall agree, in good
faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments, whose determination
shall be final and binding and whose fees and expenses shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;<U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, indebtedness, property or options by
way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, other than
a distribution of Common Stock covered by Section 2(b)) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this
Warrant, then, in each such case, provision shall be made so that upon exercise of this Warrant, the Holder shall be entitled to participate
in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Maximum Percentage) immediately before the date on which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of Common Stock are to be determined for the participation in such Distribution (provided,
however, to the extent that the Holder&rsquo;s right to participate in any such Distributions would result in the Holder exceeding the
Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (or the beneficial ownership
of any such Common Stock as a result of such Distribution to such extent) and such Distribution to such extent shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;<U>[INTENTIONALLY
OMITTED]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.&nbsp;<U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Bylaws or through any reorganization, transfer
of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid
or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all
the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality
of the foregoing, the Company (i) shall not increase the par value of the Common Stock underlying the Warrant Shares receivable upon the
exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and non-assessable Common Stock upon the exercise of this Warrant,
and (iii) shall, so long as the Warrant is outstanding, take all action necessary to reserve and keep available out of its authorized
and unissued Common Stock, solely for the purpose of effecting the exercise of the Warrant Shares, the maximum number of shares of Common
Stock as shall from time to time be necessary to effect the exercise of the Warrant then outstanding; provided, however, that such amount
of reserved shares of Common Stock shall be limited by the Maximum Percentage of Common Stock as set forth in Section 1(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;<U>WARRANT
HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of Common Stock of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the
Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with
the giving thereof to the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7.&nbsp;<U>REISSUANCE
OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(a)&nbsp;<U>Transfer
of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may
request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number
of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing
the right to purchase the number of Warrant Shares not being transferred. If, at the time of the surrender of this Warrant in connection
with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration
statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or
manner-of-sale restrictions or current public information requirements pursuant to Rule 144 promulgated under the Securities Act, the
Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, provide
to the Company an opinion of counsel selected by the Holder and reasonably acceptable to the Company, the form and substance of which
opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred
securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(b)&nbsp;<U>Lost,
Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence),
and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(c)&nbsp;<U>Exchangeable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall
be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(d)&nbsp;<U>Issuance
of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i)
shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the
Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the
Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued
in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance
date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions
as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8.&nbsp;<U>REGISTRATION
RIGHTS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(a)&nbsp;<U>Demand
Registration. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><U>(i) Grant of Right.</U> Unless
all of the Registrable Securities (as defined below) are included in an effective registration statement with a current prospectus or
a qualified offering statement with a current registration statement, the Company, upon written demand (a &ldquo;<B>Demand Notice</B>&rdquo;)
of the Holder(s) of at least fifty-one percent (51%) of the Warrants and/or the underlying Common Stock (&ldquo;<B>Majority Holders</B>&rdquo;),
agrees to register, on one occasion, all or any portion of the Common Stock underlying this Warrant that are permitted to be registered
under the Act (collectively, the &ldquo;<B>Registrable Securities</B>&rdquo;). On such occasion, the Company will file a registration
statement with the Commission (a &ldquo;<B>Demand Registration Statement</B>&rdquo;) covering the Registrable Securities within sixty
(60) days after receipt of a Demand Notice and use its best efforts to have the registration statement declared effective promptly thereafter,
subject to compliance with review by the Commission; provided, however, that the Company shall not be required to comply with a Demand
Notice if the Company has filed a registration statement with respect to which the Holder is entitled to piggyback pursuant to Section
8(b) hereof and either: (i) the Holder has elected to participate in the offering covered by such registration statement; or (ii) if such
registration statement relates to an underwritten primary offering of securities of the Company, until the offering covered by such registration
statement has been withdrawn or until thirty days after such offering is consummated. The demand for registration may be made at any time
during a period of five years beginning on the date of commencement of sales of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <U>Terms</U>. The Company
shall bear all fees and expenses attendant to the Demand Registration Statement pursuant to Section 8(a)(i), but the Holder(s) shall pay
any and all underwriting commissions and the expenses of any legal counsel selected by the Holder(s) to represent the Holder(s) in connection
with the sale of the Registrable Securities. The Company agrees to use its best efforts to cause the filing of a Demand Registration Statement
required herein to become effective promptly and to qualify or register the Registrable Securities in such states as are reasonably requested
by the Holder(s); provided, however, that in no event shall the Company be required to register the Registrable Securities in a state
in which such registration would cause: (i) the Company to be obligated to register or license to do business in such State or submit
to general service of process in such State, or (ii) the principal stockholders of the Company to be obligated to escrow their Common
Stock of the Company. The Company shall cause any registration statement filed pursuant to the demand right granted under Section 8(a)(i)
to remain effective for a period of at least 12 consecutive months after the date that the Holders of the Registrable Securities covered
by such registration statement are first given the opportunity to sell all of such securities. The Holder(s) shall only use the prospectuses
provided by the Company to sell the shares of Common Stock covered by such registration statement, and will immediately cease to use any
prospectus furnished by the Company if the Company advises the Holder(s) that such prospectus may no longer be used due to a material
misstatement or omission. Notwithstanding the provisions of this Section 8(a)(ii), the Holder(s) shall be entitled to a Demand Registration
Statement under this Section 8(a)(ii) on only one occasion and such demand registration right shall terminate on the fifth anniversary
of the commencement of sales of the offering in accordance with FINRA Rule 5110(g)(8)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(b)&nbsp;<U>&ldquo;Piggy-Back&rdquo;
Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Grant of Right</U>. Unless
all of the Registrable Securities are included in an effective registration statement with a current prospectus or a qualified offering
statement with a current offering circular, the Holder shall have the right, for a period of five years commencing on the commencement
of sales of the offering, to include the remaining Registrable Securities as part of any other registration of securities filed by the
Company (other than in connection with a transaction contemplated by Rule 145 promulgated under the Act or pursuant to Form S-3 or any
equivalent form).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <U>Terms</U>. The Company
shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 8(b)(i) hereof, but the Holder(s)
shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holder(s) to represent them in connection
with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish the then Holders
of outstanding Registrable Securities with not less than 30 days written notice prior to the proposed date of filing of such registration
statement. Such notice to the Holder(s) shall continue to be given for each registration statement filed by the Company until such time
as all of the Registrable Securities have been registered under an effective registration statement. The holders of the Registrable Securities
shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice, within ten days of the receipt of the
Company&rsquo;s notice of its intention to file a registration statement. Except as otherwise provided in this Warrant, there shall be
no limit on the number of times the Holder may request registration under this Section 8(b)(ii). Notwithstanding the provisions of this
Section 8(b)(ii), such piggyback registration rights shall terminate on the fifth anniversary of the commencement of sales of the offering
in accordance with FINRA Rule 5110(g)(8)(D).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9.&nbsp;<U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with Section 5.4 of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions
taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without limiting
the generality of the foregoing, the Company will give written notice to the Holder (i) as soon as practicable upon each adjustment of
the Exercise Price and the number of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s)
and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any
dividend or distribution upon the Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities
or rights to purchase stock, warrants, securities, indebtedness, or other property pro rata to holders of Common Stock or (C) for determining
rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information (to
the extent it constitutes, or contains, material, non-public information regarding the Company shall be made known to the public prior
to or in conjunction with such notice being provided to the Holder and (iii) at least ten (10) Trading Days prior to the consummation
of any Fundamental Transaction. It is expressly understood and agreed that the time of execution specified by the Holder in each Exercise
Notice shall be definitive and may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10.&nbsp;<U>AMENDMENT
AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant (other than Section 1(f)) may be amended and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Holder. The Holder shall be entitled, at its option, to the benefit of any amendment of any other similar warrant
issued under the Securities Purchase Agreement. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11.&nbsp;<U>SEVERABILITY</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">12.&nbsp;<U>GOVERNING
LAW</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company
in any other jurisdiction to collect on the Company&rsquo;s obligations to the Holder or to enforce a judgment or other court ruling in
favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">13.&nbsp;<U>CONSTRUCTION;
HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any
Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed
to such terms on the Closing Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents unless otherwise
consented to in writing by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">14.&nbsp;<U>DISPUTE
RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price, the Closing Sale Price, the Closing Bid Price,
the Bid Price or fair market value or the arithmetic calculation of the Warrant Shares (as the case may be), the Company or the Holder
(as the case may be) shall submit the disputed determinations or arithmetic calculations (as the case may be) via facsimile (i) within
two (2) Business Days after receipt of the applicable notice giving rise to such dispute to the Company or the Holder (as the case may
be) or (ii) if no notice gave rise to such dispute, at any time after the Holder or the Company (as the case may be) learned of the circumstances
giving rise to such dispute. If the Holder and the Company are unable to agree upon such determination or calculation (as the case may
be) of the Exercise Price, the Closing Sale Price, the Closing Bid Price, the Bid Price or fair market value or the number of Warrant
Shares (as the case may be) within three (3) Business Days of such disputed determination or arithmetic calculation being submitted to
the Company or the Holder (as the case may be), then the Company shall, within two (2) Business Days submit via facsimile (a) the disputed
arithmetic calculation of the Warrant Shares, the disputed determination of the Exercise Price, the Closing Sale Price, the Closing Bid
Price, the Bid Price or fair market value (as the case may be) to an independent, reputable investment bank selected by the Holder, with
the consent of the Company (which may not be unreasonably withheld, conditioned or delayed), or (b) if acceptable to the Holder, the disputed
arithmetic calculation of the Warrant Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense
the investment bank or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify
the Company and the Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations
or calculations (as the case may be). Such investment bank&rsquo;s or accountant&rsquo;s determination or calculation (as the case may
be) shall be binding upon all parties absent demonstrable error. The fees and expenses of such investment bank or accountant shall be
borne by the parties in the same proportion as the respective amounts by which the investment bank&rsquo;s or accountant&rsquo;s determination
differs from such party&rsquo;s calculation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">15.&nbsp;<U>REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages
for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments,
exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly
provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach
by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company therefore agrees that, in the event
of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to
an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.
The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm
the Company&rsquo;s compliance with the terms and conditions of this Warrant (including, without limitation, compliance with Section 2
hereof). The issuance of Common Stock and certificates for Common Stock as contemplated hereby upon the exercise of this Warrant shall
be made without charge to the Holder or such shares of Common Stock for any issuance tax or other costs in respect thereof, provided that
the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery
of any certificate in a name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">16.&nbsp;<U>TRANSFER</U>.
This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">17.&nbsp;<U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(a)&nbsp;&ldquo;<B>Bid
Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price of such security on the principal securities
exchange or trading market where such security is listed or traded as reported by Bloomberg as of such time of determination, or if the
foregoing does not apply, the bid price of such security in the over-the-counter market on the electronic bulletin board for such security
as reported by Bloomberg as of such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time
of determination, the average of the bid prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo;
by OTC Markets Group Inc. (formerly Pink Sheets LLC) as of such time of determination. If the Bid Price cannot be calculated for a security
as of the particular time of determination on any of the foregoing bases, the Bid Price of such security as of such time of determination
shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree
upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 14. All
such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction
during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(b)&nbsp;&ldquo;<B>Black
Scholes Value</B>&rdquo; means the Black Scholes value of an option for one share of Common Stock at the date of the applicable Cashless
Exercise, as such Black Scholes value is determined, calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg utilizing (i) an underlying price per share of Common Stock equal to the Exercise Price, as adjusted, (ii) a risk-free
interest rate corresponding to the U.S. Treasury rate, (iii) a strike price equal to the Exercise Price in effect at the time of the applicable
Cashless Exercise, (iv) an expected volatility equal to 135%, and (v) a deemed remaining term of the Warrant of five (5) years (regardless
of the actual remaining term of the Warrant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(c)&nbsp;&ldquo;<B>Black
Scholes Value &ndash; Consideration</B>&rdquo; means the value of the applicable Option or Convertible Security (as the case may be) as
of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on
Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of the Common Stock on the Trading Day immediately
preceding the public announcement of the execution of definitive documents with respect to the issuance of such Option or Convertible
Security (as the case may be), (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining
term of such Option or Convertible Security (as the case may be) as of the date of issuance of such Option or Convertible Security (as
the case may be) and (iii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function
on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the date of issuance of
such Option or Convertible Security (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(d)&nbsp;&ldquo;<B>Black
Scholes Value &ndash; FT</B>&rdquo; means the value of the unexercised portion of this Warrant remaining on the date of the Holder&rsquo;s
request pursuant to Section 4(c), which value is calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg utilizing (i) an underlying price per share of Common Stock equal to the greater of (A) the highest Closing Sale
Price of the Common Stock during the period beginning on the Trading Day immediately preceding the earliest to occur of (1) the public
disclosure of the applicable Fundamental Transaction, (2) the consummation of the applicable Fundamental Transaction and (3) the date
on which the Holder first became aware of the applicable Fundamental Transaction and ending on the Trading Day of the Holder&rsquo;s request
pursuant to Section 4(c) and (B) the sum of the price per share of Common Stock being offered in cash in the applicable Fundamental Transaction
(if any) plus the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike
price equal to the Exercise Price in effect on the date of the Holder&rsquo;s request pursuant to Section 4(c), (iii) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the greater of (A) the remaining term of this Warrant as of the date
of the Holder&rsquo;s request pursuant to Section 4(c) and (B) the remaining term of this Warrant as of the date of consummation of the
applicable Fundamental Transaction or as of the date of the Holder&rsquo;s request pursuant to Section 4(c) if such request is prior to
the date of the consummation of the applicable Fundamental Transaction and (iv) an expected volatility equal to the greater of 135% and
the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading
Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental Transaction, (B) the consummation
of the applicable Fundamental Transaction and (C) the date on which the Holder first became aware of the applicable Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(e)&nbsp;&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(f)&nbsp;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or
required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(g)&nbsp;&ldquo;<B>Closing
Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing bid price and
the last closing trade price, respectively, for such security on the principal securities exchange or trading market where such security
is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the average of the bid prices, or the ask prices, respectively,
of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly Pink Sheets
LLC). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing
bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date shall be the fair market value
as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of
such security, then such dispute shall be resolved in accordance with the procedures in Section 14. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(h)&nbsp;&ldquo;<B>Convertible
Securities</B>&rdquo; means any capital stock or other security of the Company that is at any time and under any circumstances directly
or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital
stock or other security of the Company (including, without limitation, the Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&ldquo;<B>Transfer
Agent</B>&rdquo; means Continental Stock Transfer &amp; Trust Company, with a mailing address of 1 State Street, 30th Floor, New York,
NY 10004, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;
&ldquo;<B>Trading Market</B>&rdquo; means the New York Stock Exchange, the NYSE Amex, the Nasdaq Global Select Market, the Nasdaq Global
Market or the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(k)&nbsp;&ldquo;<B>Expiration
Date</B>&rdquo; means [&#9679;], 20[&#9679;] or, if such date falls on a day other than a Business Day or on which trading does not take
place on the principal securities exchange or trading market where the Common Stock is listed (a &ldquo;<B>Holiday</B>&rdquo;), the next
date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(l)&nbsp;&ldquo;<B>Fundamental
Transaction</B>&rdquo; means that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate
or merge with or into (whether or not the Company is the surviving entity) any other Person unless the stockholders of the Company immediately
prior to such consolidation or merger continue to hold more than 50% of the outstanding shares of Voting Stock after such consolidation
or merger, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or
assets to any other Person, in connection with which the Company is dissolved, or (3) allow any other Person to make a purchase, tender
or exchange offer that is accepted by the holders of more than 50% of the outstanding shares of Voting Stock of the Company (not including
any shares of Voting Stock of the Company held by the Person or Persons making or party to, or associated or affiliated with the Persons
making or party to, such purchase, tender or exchange offer), or (4) consummate a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with any other Person
whereby such other Person acquires more than 50% of the outstanding shares of Voting Stock of the Company (not including any shares of
Voting Stock of the Company held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination), or (ii) any &ldquo;person&rdquo; or &ldquo;group&rdquo;
(as these terms are used for purposes of Sections 13(d) and 14(d) of the 1934 Act and the rules and regulations promulgated thereunder)
is or shall become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of 50% of
the aggregate ordinary voting power represented by issued and outstanding Voting Stock of the Company; provide however that a Fundamental
Transaction shall not include the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(m)&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(n)&nbsp;&ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent
equity security is quoted or listed on a Trading Market, or, if there is more than one such Person or Parent Entity, the Person or Parent
Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(o)&nbsp;&ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(p)&nbsp;&ldquo;<B>Successor
Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been
entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(q)&nbsp;&ldquo;<B>Trading
Day</B>&rdquo; means, as applicable, (x) with respect to all price determinations relating to the Common Stock, any day on which the Common
Stock is traded on the principal securities exchange or securities market on which the Common Stock is then traded, provided that &ldquo;Trading
Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours
or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange
or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00
p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or (y) with respect to all determinations
other than price determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any successor thereto)
is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(r)&nbsp;&ldquo;<B>Voting
Stock</B>&rdquo; of a Person means capital stock of such Person of the class or classes pursuant to which the holders thereof have the
general voting power to elect, or the general power to appoint, at least a majority of the board of directors, managers or trustees of
such Person (irrespective of whether or not at the time capital stock of any other class or classes shall have or might have voting power
by reason of the happening of any contingency).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">(s)&nbsp;&ldquo;<B>VWAP</B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the principal securities exchange
or securities market on which such security is then traded during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00
p.m., New York time, as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or, if the foregoing does not apply,
the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security
during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if
no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the three highest closing
bid prices and the three lowest closing ask prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo;
by OTC Markets Group Inc. (formerly Pink Sheets LLC). If VWAP cannot be calculated for such security on such date on any of the foregoing
bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If
the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section 14. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"><B></B></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>IN WITNESS WHEREOF, </B>the
Company has caused this Common Stock Purchase Warrant to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt"><B>GD CULTURE GROUP LIMITED</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">By: </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">EXERCISE NOTICE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">TO BE EXECUTED
BY THE REGISTERED HOLDER TO EXERCISE THIS COMMON STOCK PURCHASE WARRANT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">GD CULTURE GROUP
LIMITED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The undersigned holder
hereby exercises the right to purchase _____ shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;), par value $0.0001
per share, of GD Culture Group Limited, a Nevada company (the &ldquo;<B>Company</B>&rdquo;), evidenced by Common Stock Purchase
Warrant No. _____ (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall have the
respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Form
of Exercise Price</U>. The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 1.5pt; text-align: justify; width: 0.5in"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: justify; width: 1.5in">____________</TD><TD STYLE="padding-bottom: 1.5pt; text-align: justify">a
                                            &ldquo;<U>Cash Exercise</U>&rdquo; with respect to <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                            </U> &nbsp;Warrant Shares; and/or</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 1.5in">____________</TD><TD STYLE="text-align: justify">a
                                            &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                            </U>&nbsp;  Warrant Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In the event that the Holder
has elected a Cashless Exercise with respect to some or all of the Warrant Shares, the Holder represents and warrants that the shares
of Common Stock are to be delivered pursuant to such Cashless Exercise, as further specified in Annex A to this Exercise Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Payment of
Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares, the
Holder shall pay the Aggregate Exercise Price in the sum of $<U>&#9;</U> to the Company in accordance with the terms of the
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Delivery of
Warrant Shares and Net Number of Shares of Common Stock</U>. The Company shall deliver to Holder, or its designee or agent as
specified below, <U>&#9;</U> shares of Common Stock in respect of the exercise contemplated hereby. Delivery shall be made to
Holder, or for its benefit, to the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:_______________,<U STYLE="text-decoration: none">___</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Name of Registered Holder</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 30%; text-align: right">Account Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 34%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: left">(if electronic book entry transfer)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">Transaction Code Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;(if electronic book entry transfer)</TD></TR>
  </TABLE>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">ANNEX A TO EXERCISE
NOTICE CASHLESS EXERCISE EXCHANGE CALCULATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">TO BE FILLED IN
BY THE REGISTERED HOLDER TO EXCHANGE THE COMMON STOCK PURCHASE WARRANT TO IN A CASHLESS EXERCISE PURSUANT TO SECTION 1(d) OF THE WARRANT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Capitalized terms used herein
and not otherwise defined shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Net Number = (A x B)/C =
&#9;shares of Common Stock</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: 0.5in">OR</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Net Number = (C - D) x A / C</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">For purposes of the foregoing formula:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">A=</TD><TD STYLE="text-align: justify">the
total number of shares of Common Stock with respect to which the Warrant is then being exercised = ____________.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">B=</TD><TD STYLE="text-align: justify">Black Scholes Value(as defined in Section 17 of the Warrant) = ____________.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.5in">C=</TD><TD STYLE="text-align: justify">the
Closing Bid Price of the Common Stock as of two (2) Trading Days prior to the time of such exercise (as such Closing Bid Price is defined
in Section 17 of the Warrant) =____________. </TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Date:_______________,<U STYLE="text-decoration: none">___</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Name of Registered Holder</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">ACKNOWLEDGMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Company hereby acknowledges
this Exercise Notice and hereby directs ____________.to issue the above indicated number of share of Common Stock in accordance with
the Transfer Agent Instructions dated ____________, 20 ____., from the Company and acknowledged and agreed to by ____________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>GD CULTURE GROUP LIMITED</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">23</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea178802ex4-2_gdculture.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SECURITIES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO A LOCK-UP PERIOD OF ONE HUNDRED AND EIGHTY (180) DAYS FOLLOWING THE COMMENCEMENT OF SALES OF THE OFFERING PURSUANT TO THE
PROSPECTUS SUPPLEMENT TO THE REGISTRATION STATEMENT OF THE COMPANY&rsquo;S SECURITIES (FILE NO. 333-254366) AND MAY NOT BE (A) SOLD, TRANSFERRED,
ASSIGNED, PLEDGED OR HYPOTHECATED TO ANYONE OTHER THAN UNIVEST SECURITIES, LLC, OR BONA FIDE OFFICERS OR PARTNERS OF UNIVEST SECURITIES,
LLC, OR (B) CAUSED TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE
ECONOMIC DISPOSITION OF THIS SECURITIES HEREUNDER, EXCEPT AS PROVIDED FOR IN FINRA RULE 5110(E)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR
TO NOVEMBER 16, 2023. VOID AFTER 5:00 P.M., EASTERN TIME, MAY 16, 2028.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT&rsquo;S WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE PURCHASE OF 115,452 SHARES OF COMMON
STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GD CULTURE GROUP LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.&nbsp;<U>Purchase
Warrant</U>. THIS CERTIFIES THAT, pursuant to that certain placement agency agreement dated May 1, 2023 (the &ldquo;<B>Placement Agency
Agreement</B>&rdquo;), by and between GD Culture Group Limited, a Nevada company (the &ldquo;<B>Company</B>&rdquo;), on the one hand,
and Univest Securities, LLC (the &ldquo;<B>Holder</B>&rdquo; or the &ldquo;<B>Placement Agent</B>&rdquo;), on the other hand, the Holder,
as registered owner of this Purchase Warrant, is entitled, at any time or from time to time from November 16, 2023<SUP>1</SUP> (the
&ldquo;<B>Exercise Date</B>&rdquo;), and at or before 5:00 p.m., Eastern time, on May 16, 2028<SUP>2</SUP>, (the &ldquo;<B>Expiration
Date</B>&rdquo;), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to such number of shares of Common
Stock of the Company, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;), as equal to five percent (5%) of the aggregate
number of Offered Shares, Warrants and Pre-Funded Warrants sold in the Placement (the &ldquo;<B>Shares&rdquo;</B>) for an aggregate purchase
price of $100, subject to adjustment as provided in&nbsp;<U>Section 6</U>&nbsp;hereof. If the Expiration Date is a day on which banking
institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such
a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action
that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $10.02 per share of Common Stock (which
is equal to one hundred twenty percent (120%) of the offering price in the Placement);&nbsp;<I>provided, however,</I>&nbsp;that upon the
occurrence of any of the events specified in&nbsp;<U>Section 6</U>&nbsp;hereof, the rights granted by this Purchase Warrant, including
the exercise price per share of Common Stock and the number of shares of Common Stock to be received upon such exercise, shall be adjusted
as therein specified. The term &ldquo;<B>Exercise Price</B>&rdquo; shall mean the initial exercise price as set forth above or the adjusted
exercise price as a result of the events set forth in <U>Section 6</U> below, depending on the context. Capitalized terms not defined
herein shall have the meaning ascribed to them in the Placement Agency Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify"><U>Exercise</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;<U>Exercise
Form</U>. In order to exercise this Purchase Warrant, the exercise form attached hereto as&nbsp;<U>Exhibit A</U>&nbsp;must be duly executed
and completed and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Common Stock
being purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified
check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern Time, on the Expiration Date,
this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> six months from the commencement of sales of the securities
being offered in the placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP> five years from the commencement of sales of the securities
being offered in the placement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;<U>Cashless
Exercise</U>. At any time after the Exercise Date and until the Expiration Date, Holder may elect to receive the number of shares of Common
Stock equal to the value of this Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to the
Company, together with the exercise form attached hereto, in which event the Company shall issue to Holder, Shares in accordance with
the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD ROWSPAN="2" STYLE="width: 7%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD ROWSPAN="2" STYLE="width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="vertical-align: top; width: 8%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y(A-B)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 82%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where,</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of Common Stock to be issued to Holder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of Common Stock for which the Purchase Warrant is being exercised;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair market value of one share of Common Stock; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Exercise Price.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this&nbsp;<U>Section
2.2</U>, the &ldquo;fair market value&rdquo; of a share of Common Stock is defined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">if the Common Stock is traded on a national securities exchange, the value shall be deemed to be the closing
price on such exchange for the five consecutive trading days ending on the day immediately prior to the exercise form being submitted
in connection with the exercise of the Purchase Warrant; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">if the Common Stock is actively traded over-the-counter, the value shall be deemed to be the weighted
average price of the Common Stock for the five consecutive trading days ending on the trading day immediately prior to the exercise form
being submitted in connection with the exercise of the Purchase Warrant; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">if there is no market for the Common Stock, the value shall be the fair market value thereof, as determined
in good faith by the Company&rsquo;s Board of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">2.3&nbsp;<U>Legend</U>.
Each certificate for the securities purchased under this Purchase Warrant shall bear the following legends unless such securities have
been registered under the Securities Act of 1933, as amended (the &ldquo;<B>Act</B>&rdquo;), or are exempt from registration under the
Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45pt 0pt 1.5in; text-align: justify">(i) &ldquo;THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD OF ONE HUNDRED AND EIGHTY (180) DAYS FOLLOWING THE COMMENCEMENT OF SALES OF THE OFFERING
PURSUANT TO THE PROSPECTUS SUPPLEMENT TO THE REGISTRATION STATEMENT OF THE COMPANY&rsquo;S SECURITIES (FILE NO. 333-254366) AND MAY NOT
BE (A) SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED TO ANYONE OTHER THAN UNIVEST SECURITIES, LLC, OR BONA FIDE OFFICERS OR PARTNERS
OF UNIVEST SECURITIES, LLC, OR (B) CAUSED TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL TRANSACTION THAT WOULD
RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THIS SECURITIES HEREUNDER, EXCEPT AS PROVIDED FOR IN FINRA RULE 5110(E)(2).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45pt 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45pt 0pt 1.5in; text-align: justify">(ii) Any legend required by the securities
laws of any state to the extent such laws are applicable to the Shares represented by a certificate, instrument, or book entry so legended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify"><U>Transfer</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;<U>General
Restrictions</U>. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder will not:
(a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days following the commencement
of sales of the public offering to anyone other than: (i) the Placement Agent or a selected dealer participating in the Placements, or
(ii) a bona fide officer or partner of the Placement Agent or of any such selected dealer, in each case in accordance with FINRA Rule
5110(e)(1), or (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative,
put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder,
except as provided for in FINRA Rule 5110(e)(2). On and after that date that is one hundred eighty (180) days after the commencement of
sales of the offering, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. In order
to make any permitted assignment, the Holder must deliver to the Company the assignment form attached hereto as&nbsp;<U>Exhibit B</U>&nbsp;duly
executed and completed, together with this Purchase Warrant and payment of all transfer taxes, if any, payable in connection therewith.
The Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver
a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the
aggregate number of shares of Common Stock purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;<U>Restrictions
Imposed by the Act</U>. The securities evidenced by this Purchase Warrant shall not be transferred unless and until: (i) the Company has
received the opinion of counsel for the Company that the securities may be transferred pursuant to an exemption from registration under
the Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company,
(ii) a registration statement or a post-effective amendment to the Registration Statement relating to the offer and sale of such securities
that has been declared effective by the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) and includes a current
prospectus or (iii) a registration statement, relating to the offer and sale of such securities has been filed and declared effective
by the Commission and compliance with applicable state securities law has been established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify"><U>Registration Rights</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">4.1</TD><TD STYLE="text-align: justify"><U>Demand Registration</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1.1&nbsp;<U>Grant
of Right</U>. Unless all of the Registrable Securities (as defined below) are included in an effective registration statement with a current
prospectus or a qualified offering statement with a current registration statement, the Company, upon written demand (a &ldquo;<B>Demand
Notice</B>&rdquo;) of the Holder(s) of at least fifty-one percent (51%) of the Warrants and/or the underlying shares of Common Stock (&ldquo;<B>Majority
Holders</B>&rdquo;), agrees to register, on one occasion, all or any portion of the shares of Common Stock underlying this Purchase Warrant
that are permitted to be registered under the Act (collectively, the &ldquo;<B>Registrable Securities</B>&rdquo;). On such occasion, the
Company will file a registration statement with the Commission (a &ldquo;<B>Demand Registration Statement</B>&rdquo;) covering the Registrable
Securities within sixty (60) days after receipt of a Demand Notice and use its best efforts to have the registration statement declared
effective promptly thereafter, subject to compliance with review by the Commission; provided, however, that the Company shall not be required
to comply with a Demand Notice if the Company has filed a registration statement with respect to which the Holder is entitled to piggyback
pursuant to Section 4.2 hereof and either: (i) the Holder has elected to participate in the offering covered by such registration statement;
or (ii) if such registration statement relates to an underwritten primary offering of securities of the Company, until the offering covered
by such registration statement has been withdrawn or until thirty days after such offering is consummated. The demand for registration
may be made at any time during a period of five years beginning on the date of commencement of sales of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1.2&nbsp;<U>Terms</U>.
The Company shall bear all fees and expenses attendant to the Demand Registration Statement pursuant to <U>Section 4.1.1</U>, but the
Holder(s) shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holder(s) to represent
the Holder(s) in connection with the sale of the Registrable Securities. The Company agrees to use its best efforts to cause the filing
of a Demand Registration Statement required herein to become effective promptly and to qualify or register the Registrable Securities
in such states as are reasonably requested by the Holder(s); provided, however, that in no event shall the Company be required to register
the Registrable Securities in a state in which such registration would cause: (i) the Company to be obligated to register or license to
do business in such State or submit to general service of process in such State, or (ii) the principal stockholders of the Company to
be obligated to escrow their Common Stock of the Company. The Company shall cause any registration statement filed pursuant to the demand
right granted under <U>Section 4.1.1</U> to remain effective for a period of at least 12 consecutive months after the date that the Holders
of the Registrable Securities covered by such registration statement are first given the opportunity to sell all of such securities. The
Holder(s) shall only use the prospectuses provided by the Company to sell the shares of Common Stock covered by such registration statement,
and will immediately cease to use any prospectus furnished by the Company if the Company advises the Holder(s) that such prospectus may
no longer be used due to a material misstatement or omission. Notwithstanding the provisions of this <U>Section 4.1.2</U>, the Holder(s)
shall be entitled to a Demand Registration Statement under this <U>Section 4.1.2</U> on only one occasion and such demand registration
right shall terminate on the fifth anniversary of the commencement of sales of the offering in accordance with FINRA Rule 5110(g)(8)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">4.2</TD><TD STYLE="text-align: justify"><U>&ldquo;Piggy-Back&rdquo; Registration.</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.1&nbsp;<U>Grant
of Right</U>. Unless all of the Registrable Securities are included in an effective registration statement with a current prospectus or
a qualified offering statement with a current offering circular, the Holder shall have the right, for a period of five years commencing
on the commencement of sales of the offering, to include the remaining Registrable Securities as part of any other registration of securities
filed by the Company (other than in connection with a transaction contemplated by Rule 145 promulgated under the Act or pursuant to Form
F-3 or any equivalent form).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.2&nbsp;<U>Terms</U>.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to <U>Section 4.2.1</U> hereof,
but the Holder(s) shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holder(s) to represent
them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish
the then Holders of outstanding Registrable Securities with not less than 30 days written notice prior to the proposed date of filing
of such registration statement. Such notice to the Holder(s) shall continue to be given for each registration statement filed by the Company
until such time as all of the Registrable Securities have been registered under an effective registration statement. The holders of the
Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice, within ten days
of the receipt of the Company&rsquo;s notice of its intention to file a registration statement. Except as otherwise provided in this Purchase
Warrant, there shall be no limit on the number of times the Holder may request registration under this <U>Section 4.2.2</U>. Notwithstanding
the provisions of this <U>Section 4.2.2</U>, such piggyback registration rights shall terminate on the fifth anniversary of the commencement
of sales of the offering in accordance with FINRA Rule 5110(g)(8)(D).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: justify"><U>New Purchase Warrants to be Issued</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;<U>Partial
Exercise or Transfer</U>. Subject to the restrictions in <U>Section 3</U> hereof, this Purchase Warrant may be exercised or assigned in
whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation,
together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised
pursuant to <U>Section 2.1 </U>hereof, the Company shall cause to be delivered to the Holder without charge a new Purchase Warrant of
like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number of shares of Common
Stock purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;<U>Lost
Certificate</U>. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase
Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase
Warrant of like tenor and effective date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation
or destruction shall constitute a substitute contractual obligation on the part of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">6.</TD><TD STYLE="text-align: justify"><U>Adjustments</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1&nbsp;<U>Adjustments
to Exercise Price and Number of shares of Common Stock</U>. The Exercise Price and the number of shares of Common Stock underlying this
Purchase Warrant shall be subject to adjustment from time to time as hereinafter set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.1&nbsp;<U>Stock
Dividends; Split Ups</U>. If, after the date hereof, and subject to the provisions of&nbsp;<U>Section 6.3</U>&nbsp;below, the number of
outstanding shares of Common Stock is increased by a stock dividend payable in Common Stock or by a split up of Commo Stock or other similar
event, then, on the effective day thereof, the number of shares of Common Stock purchasable hereunder shall be increased in proportion
to such increase in outstanding shares of Common Stock, and the Exercise Price shall be proportionately decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.2&nbsp;<U>Aggregation
of Common Stock</U>. If, after the date hereof, and subject to the provisions of&nbsp;<U>Section 6.3</U>&nbsp;below, the number of outstanding
shares of Common Stock is decreased by a consolidation, combination or reclassification of Ordinary Shares or other similar event, then,
on the effective date thereof, the number of shares of Common Stock purchasable hereunder shall be decreased in proportion to such decrease
in outstanding shares, and the Exercise Price shall be proportionately increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.3&nbsp;<U>Replacement
of Common Stock upon Reorganization, etc</U>. In case of any reclassification or reorganization of the outstanding shares of Common Stock
other than a change covered by&nbsp;<U>Section 6.1.1</U>&nbsp;or&nbsp;<U>Section 6.1.2</U>&nbsp;hereof or that solely affects the par
value of such Common Stock, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another
corporation (other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and
that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale
or conveyance to another corporation or entity of the property of the Company as an entirety or substantially as an entirety in connection
with which the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the
right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder
immediately prior to such event, the kind and amount of common stock or other securities or property (including cash) receivable upon
such reclassification, reorganization, share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such
sale or transfer, by a Holder of the number of shares of Common Stock of the Company obtainable upon exercise of this Purchase Warrant
immediately prior to such event; and if any reclassification also results in a change in shares of Common Stock covered by&nbsp;<U>Section
6.1.1</U>&nbsp;or&nbsp;<U>Section 6.1.2</U>, then such adjustment shall be made pursuant to&nbsp;<U>Section 6.1.1</U>,&nbsp;<U>Section
6.1.2</U>&nbsp;and this&nbsp;<U>Section 6.1.3</U>. The provisions of this&nbsp;<U>Section 6.1.3&nbsp;</U>shall similarly apply to successive
reclassifications, reorganizations, stock reconstructions or amalgamations, or consolidations, sales or other transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.4 &nbsp;<U>Fundamental
Transaction.</U>&nbsp;If, at any time while this Purchase Warrant is outstanding, the Company enters into the following transactions with
another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock
(not including any Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with, the other
Persons making or party to such stock purchase agreement or other business combination): (i) the Company, directly or indirectly, in one
or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares of Common Stock for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding shares
of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the shares of Common Stock or any compulsory stock exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spinoff or scheme of arrangement) with another Person or group of Persons (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then,
upon any subsequent exercise of this Purchase Warrant, the Holder shall have the right to receive, for each Purchase Warrant Share that
would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of shares
of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional or
alternative consideration (the &ldquo;<B>Alternative Consideration</B>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Purchase Warrant is exercisable immediately prior to such Fundamental
Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternative Consideration based on the amount of Alternative Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternative Consideration in a reasonable manner reflecting
the relative value of any different components of the Alternative Consideration. If holders of Common Stock are given any choice as to
the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the
Alternative Consideration it receives upon any exercise of this Purchase Warrant following such Fundamental Transaction. The Company shall
cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor Entity</B>&rdquo;)
to assume in writing all of the obligations of the Company under this Purchase Warrant, and to deliver to the Holder in exchange for this
Purchase Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Purchase Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the Common Stock acquirable and receivable upon exercise of this Purchase Warrant prior to such Fundamental Transaction,
and with an exercise price which applies the Exercise Price hereunder to such shares of capital stock (but taking into account the relative
value of the Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
of capital stock and such exercise price being for the purpose of protecting the economic value of this Purchase Warrant immediately prior
to the consummation of such Fundamental Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Purchase Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise
every right and power of, the Company and shall assume all of the obligations of the Company, under this Purchase Warrant and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.5&nbsp;<U>Changes
in Form of Purchase Warrant</U>. This form of Purchase Warrant need not be changed because of any change pursuant to this&nbsp;<U>Section
6.1</U>, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of shares of Common Stock
as are stated in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new
Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after
the date hereof or the computation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2&nbsp;<U>Substitute
Purchase Warrant</U>. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company with or
into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in any reclassification
or change of the outstanding shares of Common Stock), the corporation formed by such consolidation or stock reconstruction or amalgamation
shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase Warrant then outstanding
or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise
of such Purchase Warrant, the kind and amount of the Common Stock and other securities and property receivable upon such consolidation
or stock reconstruction or amalgamation, by a holder of the number of shares of Common Stock of the Company for which such Purchase Warrant
might have been exercised immediately prior to such consolidation, stock reconstruction or amalgamation, sale or transfer. Such supplemental
Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided for in this&nbsp;<U>Section 6</U>.
The above provision of this&nbsp;<U>Section 6</U>&nbsp;shall similarly apply to successive consolidations or share reconstructions or
amalgamations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3&nbsp;<U>Elimination
of Fractional Interests</U>. The Company shall not be required to issue certificates representing fractions of shares of Common Stock
upon the exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it
being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may
be, to the nearest whole number of shares of Common Stock or other securities, properties or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.&nbsp;<U>Reservation
and Listing</U>. The Company shall at all times reserve and keep available out of its authorized Common Stock, solely for the purpose
of issuance upon exercise of this Purchase Warrant, such number of shares of Common Stock or other securities, properties or rights as
shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Warrant and payment
of the Exercise Price therefor, in accordance with the terms hereby, all shares of Common Stock and other securities issuable upon such
exercise shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any stockholder. The
Company further covenants and agrees that upon exercise of this Purchase Warrant and payment of the exercise price therefor, all shares
of Common Stock and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and not
subject to preemptive rights of any stockholder. As long as this Purchase Warrant shall be outstanding, the Company shall use its commercially
reasonable efforts to cause all shares of Common Stock issuable upon exercise of this Purchase Warrant to be listed (subject to official
notice of issuance) on all national securities exchanges (or, if applicable, on the OTCQB Market or any successor quotation system) on
which the shares of Common Stock issued to the public in the Offering may then be listed and/or quoted (if at all).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">8.</TD><TD STYLE="text-align: justify"><U>Certain Notice Requirements</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1&nbsp;<U>Holder&rsquo;s
Right to Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive
notice as a stockholder for the election of directors or any other matter, or as having any rights whatsoever as a stockholder of the
Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events described in&nbsp;<U>Section
8.2</U>&nbsp;shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen days
prior to the date fixed as a record date or the date of closing the transfer books (the &ldquo;<B>Notice Date</B>&rdquo;) for the determination
of the stockholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing
of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice
given to the other stockholders of the Company at the same time and in the same manner that such notice is given to the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2&nbsp;<U>Events
Requiring Notice</U>. The Company shall be required to give the notice described in this&nbsp;<U>Section 8</U>&nbsp;upon one or more of
the following events: (i) if the Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive
a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings,
as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer to
all the holders of its Common Stock any additional stock capital of the Company or securities convertible into or exchangeable for shares
in the capital of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding up
of the Company (other than in connection with a consolidation or stock reconstruction or amalgamation) or a sale of all or substantially
all of its property, assets and business shall be proposed.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3&nbsp;<U>Notice
of Change in Exercise Price</U>. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to&nbsp;<U>Section
6</U>&nbsp;hereof, send notice to the Holders of such event and change (&ldquo;<B>Price Notice</B>&rdquo;). The Price Notice shall describe
the event causing the change and the method of calculating same and shall be certified as being true and accurate by the Chief Executive
Officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8.4&nbsp;<U>Transmittal
of Notices</U>. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be
deemed to have been duly made if made in accordance with the notice provisions of the Placement Agency Agreement to the addresses and
contact information set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>If to the Holder, then to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Univest Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">75 Rockefeller Plaza #1838</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, NY 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn: &#9;Edric Guo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Email: &#9;yguo@univest.us</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>With a copy to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Hunter Taubman Fischer &amp; Li LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">950 Third Avenue, 19<SUP>th</SUP> Floor,<BR>
New York, NY 10022<BR>
Attn: &#9;Ying Li, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Email: &#9;yli@htflawyers.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>If to the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">GD Culture Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Flat 1512, 15F, Lucky Centre,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">No.165-171 Wan Chai Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Wan Chai, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Xiaojian Wang</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: xiaojian.gdc@gmail.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>With a copy to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Ortoli Rosenstadt LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">366 Madison Avenue, 3<SUP>rd</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn: Mengyi &ldquo;Jason&rdquo; Ye, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Emails: &#9;jye@orllp.legal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">9.</TD><TD STYLE="text-align: justify"><U>Miscellaneous</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.1&nbsp;<U>Amendments</U>.
The Company and the Placement Agent may from time to time supplement or amend this Purchase Warrant without the approval of any of the
Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent
with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and the Placement Agent may deem necessary or desirable and that the Company and the Placement Agent deem shall not adversely affect the
interest of the Holders. All other modifications or amendments shall require the written consent of and be signed by the party against
whom enforcement of the modification or amendment is sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.2&nbsp;<U>Headings</U>.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Purchase Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.3.&nbsp;<U>Entire
Agreement</U>. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection with
this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.4&nbsp;<U>Binding
Effect</U>. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their
permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed to have any
legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.5&nbsp;<U>Governing
Law; Submission to Jurisdiction; Trial by Jury</U>. This Purchase Warrant shall be governed by and construed and enforced in accordance
with the internal laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees
that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced
in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in&nbsp;<U>Section
8</U>&nbsp;hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other
party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection
with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.6&nbsp;<U>Waiver,
etc</U>. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed
or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof
or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.7&nbsp;<U>Exchange
Agreement</U>. As a condition of the Holder&rsquo;s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior
to the complete exercise of this Purchase Warrant by Holder, if the Company and the Placement Agent enter into an agreement (&ldquo;<B>Exchange
Agreement</B>&rdquo;) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or
a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.8&nbsp;<U>Execution
in Counterparts</U>. This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto in separate
counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement,
and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other
parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.9&nbsp;<U>Holder
Not Deemed a Stockholder</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this
Purchase Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Purchase Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of
this Purchase Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate
action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive
notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Shares which it
is then entitled to receive upon the due exercise of this Purchase Warrant. In addition, nothing contained in this Purchase Warrant shall
be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Purchase Warrant or otherwise)
or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.10&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Shares acquired upon the exercise of this Purchase Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.11&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Purchase Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Purchase Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this
Purchase Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Company has caused
this Purchase Warrant to be signed by its duly authorized officer as of the 16th day of May, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GD Culture Group Limited</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Xiaojian Wang </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exercise Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Form to be used to exercise Purchase Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Date: __________, 20___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby elects
irrevocably to exercise the Purchase Warrant for ______ shares of Common Stock of GD Culture Group Limited, a Nevada company (the &ldquo;<B>Company</B>&rdquo;)
and hereby makes payment of $____ (at the rate of $____ per share of Common Stock) in payment of the Exercise Price pursuant thereto.
Please issue the shares of Common Stock as to which this Purchase Warrant is exercised in accordance with the instructions given below
and, if applicable, a new Purchase Warrant representing the number of shares of Common Stock for which this Purchase Warrant has not been
exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby elects
irrevocably to convert its right to purchase ___ shares of Common Stock under the Purchase Warrant for ______ shares of Common Stock,
as determined in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 16%">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="width: 13%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;X</FONT></TD>
    <TD ROWSPAN="2" STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;=</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 43%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y(A-B)</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 19%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where,</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of Common Stock to be issued to Holder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of Common Stock for which the Purchase Warrant is being exercised;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair market value of one share of Common Stock which is equal to $_____; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Exercise Price which is equal to $______ per share of Common Stock</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees and
acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect to the calculation
shall be resolved by the Company in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please issue the shares of
Common Stock as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new
Purchase Warrant representing the number of shares of Common Stock for which this Purchase Warrant has not been converted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Signature Guaranteed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INSTRUCTIONS FOR REGISTRATION OF SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Print in Block Letters)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOTICE: The signature to this
form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national
securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Assignment Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Form to be used to assign Purchase Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ASSIGNMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(To be executed by the registered Holder to effect a transfer of the
within Purchase Warrant):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, _____________________ does
hereby sell, assign and transfer unto the right to purchase _______________ shares of Common Stock of GD Culture Group Limited, a Nevada
company (the &ldquo;<B>Company</B>&rdquo;), evidenced by the Purchase Warrant and does hereby authorize the Company to transfer such right
on the books of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: __________ 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature Guaranteed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOTICE: The signature to this
form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered
national securities exchange.</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">12</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea178802ex10-1_gdculture.htm
<DESCRIPTION>FORM OF AMENDMENT TO RD SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND CERTAIN PURCHASERS, DATED MAY 16, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENT TO SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Amendment to Securities Purchase Agreement
(this &ldquo;<B>Amendment</B>&rdquo;), dated as of May 16, 2023, is by and between GD Culture Group Limited, a Nevada corporation (the
&ldquo;<B>Company</B>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<B>Purchaser</B>&rdquo; and collectively the &ldquo;<B>Purchasers</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS</B>, the Company and the Purchasers
entered into that Securities Purchase Agreement dated as of May 1, 2023 (the &ldquo;<B>SPA</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS</B>, the SPA provides that &ldquo;Per
Share Purchase Price&rdquo; equals $8.27 and &ldquo;Per Pre-Funded Warrant Purchase Price&rdquo; equals $8.269;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS</B>, the Company and the Purchasers
wish to amend the SPA to increase the &ldquo;Per Share Purchase Price&rdquo; to $8.35 and the &ldquo;Per Pre-Funded Warrant Purchase Price&rdquo;
to $8.349, as set forth in this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOW, THEREFORE</B>, in consideration of the
foregoing and the respective covenants and agreements set forth herein, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>1. </B>Definition of &ldquo;Per Share Purchase
Price&rdquo; as set forth under Section 1.1 of the SPA, is hereby deleted and replaced in its entirety with the following.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;&ldquo;Per Share Purchase Price&rdquo;
equals $8.35, subject to adjustment for reverse and forward share splits, share dividends, share combinations and other similar transactions
with respect to the Common Stock that occur between the date hereof and the Closing Date.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2.</B> Definition of &ldquo;Per Pre-Funded
Warrant Purchase Price&rdquo; as set forth under Section 1.1 of the SPA, is hereby deleted and replaced in its entirety with the following.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;&ldquo;Per Pre-Funded Warrant
Purchase Price&rdquo; equals $8.349, subject to adjustment for reverse and forward share splits, share dividends, share combinations and
other similar transactions with respect to the Common Stock that occur after the date of this Agreement.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3.</B> Section 2.2(a)(vi) of the SPA is hereby
deleted and replaced in its entirety with the following.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;(vi)&#9;for each Purchaser of
Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number
of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants divided
by the Per Pre-Funded Warrant Purchase Price with an exercise price equal to $0.001, subject to adjustment therein; and&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.</B> Capitalized terms not otherwise defined
herein shall the respective meanings ascribed to them in the SPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5. </B>Except as herein above amended, the
terms and provisions of the SPA as amended shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6. </B>This Amendment may be executed in any
number of counterparts, each of which shall be considered an original for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7. </B>This Amendment shall extend to and be
binding upon the heirs, executors, administrators, successors, and assigns of each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>8. </B>This Amendment shall be governed by
and construed in accordance with the internal laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Amendment to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><B>GD CULTURE GROUP LIMITED</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left"><U>Address for Notice</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left">Flat 1512, 15F, Lucky Centre,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 4%; text-align: left"><B>By:</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; padding-bottom: 1.5pt; width: 58%; text-align: left">No.165-171 Wan Chai Road</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name: Xiaojian Wang</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left">Wan Chai, Hong Kong</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title: Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">With a copy to (which shall not constitute notice):</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Ortoli Rosenstadt LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">366 Madison Avenue, Third Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Attention: Mengyi &ldquo;Jason&rdquo; Ye</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Email: jye@orllp.legal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK<BR>
SIGNATURE PAGE FOR PURCHASERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO THE AMENDMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Amendment to the Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the
date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ______________________________________________________________<I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ______________________________________________________&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:_______________________________________________&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile Number of Authorized Signatory: ____________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Pre-Funded Warrants to Purchaser (if not same
as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Amount:</FONT></TD>
    <TD STYLE="width: 59%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;Beneficial Ownership Blocker: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded Warrants:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;Beneficial Ownership Blocker: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employer Identification Number:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &#9744; Notwithstanding anything contained
in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth
in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities
to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur no
later than the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the
above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition
and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement,
instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ea178802ex10-2_gdculture.htm
<DESCRIPTION>FORM OF AMENDMENT TO PIPE SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND CERTAIN PURCHASERS, DATED MAY 16, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENT TO SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Amendment to Securities Purchase Agreement
(this &ldquo;<B>Amendment</B>&rdquo;), dated as of May 16, 2023, is by and between GD Culture Group Limited, a Nevada corporation (the
&ldquo;<B>Company</B>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<B>Purchaser</B>&rdquo; and collectively the &ldquo;<B>Purchasers</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS</B>, the Company and the Purchasers
entered into that Securities Purchase Agreement dated as of May 1, 2023 (the &ldquo;<B>SPA</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS</B>, Section 1.1 of the SPA provides
that &ldquo;Per Warrant Purchase Price&rdquo; equals $8.27;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS</B>, the Company and the Purchasers
wish to amend the SPA to increase the &ldquo;Per Warrant Purchase Price&rdquo; to $8.35, as set forth in this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOW, THEREFORE</B>, in consideration of the
foregoing and the respective covenants and agreements set forth herein, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>1. </B>Definition of &ldquo;Per Warrant Purchase
Price&rdquo; as set forth under Section 1.1 of the SPA, is hereby deleted and replaced in its entirety with the following.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;&ldquo;Per Warrant Purchase Price&rdquo;
equals $8.35, subject to adjustment for reverse and forward share splits, share dividends, share combinations and other similar transactions
with respect to the Common Stock that occur after the date of this Agreement.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2.</B> Section 2.2(a)(vi) is hereby deleted
and replaced in its entirety with the following.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;(vi) for each Purchaser of
Common Warrants pursuant to Section 2.1, a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares
of Common Stock equal to the number stated on the Purchaser&rsquo;s signature page hereto, each with an exercise price equal to $8.35,
subject to adjustment therein.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3.</B> Capitalized terms not otherwise defined
herein shall the respective meanings ascribed to them in the SPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4. </B>Except as herein above amended, the
terms and provisions of the SPA as amended shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5. </B>This Amendment may be executed in any
number of counterparts, each of which shall be considered an original for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6. </B>This Amendment shall extend to and be
binding upon the heirs, executors, administrators, successors, and assigns of each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7. </B>This Amendment shall be governed by
and construed in accordance with the internal laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Amendment to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left"><B>GD CULTURE GROUP LIMITED</B></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left"><U>Address for Notice:</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left">Flat 1512, 15F, Lucky Centre,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: left"><B>By:</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; width: 58%; text-align: left">No.165-171 Wan Chai Road</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Name: Xiaojian Wang</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; text-align: left">Wan Chai, Hong Kong</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Title: Chief Executive Officer</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">With a copy to (which shall not constitute notice):</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">Ortoli Rosenstadt LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">366 Madison Avenue, Third Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">Attention: Mengyi &ldquo;Jason&rdquo; Ye</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">Email: jye@orllp.legal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK<BR>
SIGNATURE PAGE FOR PURCHASERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO THE AMENDMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Amendment to the Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the
date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: _________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
__________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile Number of Authorized Signatory: _____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of the Warrants to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DWAC for Offered Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Warrants: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: ____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9744; Notwithstanding anything contained in this Agreement to
the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in this Agreement to
be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed,
shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur no later than the second
(2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement
(but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement,
instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an
unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>gdc-20230516.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWa+ACaPtyJ1xeYkxuG93fenqHyYrfZB/zCzCkyhGcaoH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:GDC="http://ccnctech.com/20230516" elementFormDefault="qualified" targetNamespace="http://ccnctech.com/20230516">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://ccnctech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="gdc-20230516_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gdc-20230516_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>gdc-20230516_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>gdc-20230516_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ccnctech.com/role/Cover" xlink:href="gdc-20230516.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ccnctech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139947248618640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 16, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 16,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GD Culture Group Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001641398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3709051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">c/o GD Culture Group Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Flat 1512, 15F, Lucky Centre,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">No.165-171 Wan Chai Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wan Chai<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">HK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">00000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">95791074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GDC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>ea178802-8k_gdculture_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gdc-20230516.xsd" xlink:type="simple"/>
    <context id="From2023-05-16to2023-05-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001641398</identifier>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-16to2023-05-16">0001641398</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-16to2023-05-16">false</dei:AmendmentFlag>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-16to2023-05-16">00000</dei:EntityAddressPostalZipCode>
    <dei:DocumentType contextRef="From2023-05-16to2023-05-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-16to2023-05-16">2023-05-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-05-16to2023-05-16">GD Culture Group Limited</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-16to2023-05-16">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-05-16to2023-05-16">001-37513</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-16to2023-05-16">47-3709051</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-16to2023-05-16">c/o GD Culture Group Limited</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-05-16to2023-05-16">Flat 1512, 15F, Lucky Centre,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2023-05-16to2023-05-16">No.165-171 Wan Chai Road</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-16to2023-05-16">Wan Chai</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2023-05-16to2023-05-16">HK</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="From2023-05-16to2023-05-16">+852</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-16to2023-05-16">95791074</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-05-16to2023-05-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-05-16to2023-05-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-05-16to2023-05-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-05-16to2023-05-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-16to2023-05-16">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="From2023-05-16to2023-05-16">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-16to2023-05-16">GDC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-16to2023-05-16">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M 'L"_+]4RAQV[ N!XGW.Z!]02P,$%     @ A$JQ5I^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (1*L597<G-)=00  -L1   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "$2K%6GZ ;\+$"  #B#   #0              @ &Y#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( (1*L5:7BKL<P    !,"   +
M  "  94/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( (1*L5:JQ"(6,P$  "("
M   /              "  7X0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "$2K%6)!Z;HJT   #X 0  &@              @ '>$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "$2K%699!YDAD!  #/ P
M$P              @ '#$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"   -%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea178802-8k_gdculture.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ccnctech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressPostalZipCode -  ea178802-8k_gdculture.htm 22</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="ea178802-8k_gdculture.htm">ea178802-8k_gdculture.htm</File>
    <File>ea178802ex10-1_gdculture.htm</File>
    <File>ea178802ex10-2_gdculture.htm</File>
    <File>ea178802ex4-1_gdculture.htm</File>
    <File>ea178802ex4-2_gdculture.htm</File>
    <File>gdc-20230516.xsd</File>
    <File>gdc-20230516_lab.xml</File>
    <File>gdc-20230516_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea178802-8k_gdculture.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea178802-8k_gdculture.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gdc-20230516_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gdc-20230516_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "gdc-20230516.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "GDC",
   "nsuri": "http://ccnctech.com/20230516",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea178802-8k_gdculture.htm",
      "contextRef": "From2023-05-16to2023-05-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://ccnctech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea178802-8k_gdculture.htm",
      "contextRef": "From2023-05-16to2023-05-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-23-040663-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-040663-xbrl.zip
M4$L#!!0    ( (1*L59MQ(N^'18  !^"   9    96$Q-S@X,#(M.&M?9V1C
M=6QT=7)E+FAT;>T]:U?B2-/?.8?_T ^[\QP]PRWA)J@\![DXK(H,X.K,%T^3
M-- :$DR"P/SZM[H[@02"H@O,C/ON125]J>JZ=55U=3CYWW2HH6=B6M303R-2
M/!E!1%<,E>K]T\C8[L6.(O\KAD,G QOZ05_=.HT,;'M42"0FDTE\DHH;9C\A
MY?/YQ)3UB8A.A6E@/SF9E!)W5Y=M94"&.$9UR\:Z0N:#-*H_KI^?M<Z[=DV-
M^KJR)RZ05&)E:FA5%P.\G;,)T>CK:@=VS8BNMMN56D9:EG(OX2%ZS =,U_65
M&,ZP0G)WUKI<=+>#^R^Z)FP3ZU;/,(?8!AZRF3*QI!R3LYY)8A91?!/!YWC?
M>'YUGJ-82G+G66&.?Z6LN8NM.<55LD1N%R8TP @YY78T26_MM-D$M+H=QU:L
MC_%HWKF'K2[OZ#3X9H5GIJ$1*[ W;_%U5XRQ;INS8(R=1M\ R[17IX:'OD[G
ME?*\DZ+HBDV405PQAKQ3,B-E(URW"%;A-V+_G-C4UDCQ)"%^0^N0V!BQ.6+D
M:4R?3R-E0[>);L<ZLQ$06Q&?3B,VF=H)H8()-B[A3'ORGU@,U2C1U )J$_L8
M-?"0%-!4G1ZC>H7_<9^4R_<W[4]RY;Q4:L(OAAZ*Q38=G3J[AY7>>U=X[Z[P
M#=.DC^:CWC,\D[\G(%N /OQ7U8& LS)0QL1:75?)](+,[I-@?[)I*94_>N^\
MI2'15?C?KFFX?]_#FD7>,I6T@F))54UB64T#[)7VG8[*ADH8GLGD&^;-G@'[
M*O?2O6-N! !X])8YY/OV  ,N]_(]MZYB$HL_>\L\%89+TYDKM8+2VLF[ACI#
MECW3R&FD!U)=0%)R9*,.'4*7!IF@EC'$>E0\B (")NUQ_5'ILSM.I=9(P[,"
MT@V=\$8Z+3!%(";3,/Z)JBK1N;ZQC]"Q,1["7(I0I:G=8O:H9AI#)H.Q9"8F
M96UC\7<$Z;!J $5H(5#*(L6%F)TD?""V ]4G@Y$B%\*= %HOH7R-R60@U(2/
MR P)L.'$!+>"6*('VRH*%O<! !O$-_;"@.\#?56)N;H?GUIJQ&FUP=B=1BPZ
M'&E$&#@'DG]N <TRQJ8+#+IQ@2LXRT=4?7'YKB%VAQ%.@_G3^7.JLI8>)2;B
M*R&!^VNY?N$7A^7!"W")0'@.M!&0UU!7L0"6F'8%VZ2X6(([TZ)M91C(SYI!
M;LLR6CX$W(<.2?UT'NM4$!ET?86:0X*ML4F*CE$H0!]W,K?)#X+-MF9^86'6
M@G"(P#N]&\;"DJW  :L#;%RE+1O+]0';ANEI?CL-EG$,FM4#M$)T8TCUU\"^
M3I=EN$$3N^T^*JP0U-%0CSX*Z^ :Y),$C(??[-^3D6O$A]CL4[V DA'P@T9%
M?^.F.\,QFD\#7;U3>3:QUE@CL2;N\SW<NX^(L3';&/'Q[F2QKF';QM!Y-J&J
M/6"X)#]%?*.[A@GK$Z//-*P\(AEPL R-JL?(:71G$NW2HITM,&;1'["QPM-(
M\;]_2-GDL:"4\].S@H1O"=LFU3^=ZA@Q^Q##&NW#(P5L&S%A^NY\4=T]P+II
MU#O5"FIW2IUJ>S\@V]7R3:O>J5?;J-2HH.I=^4NI<5Y%Y>NKJWJ[7;]N[ >/
MVU+[2[UQWKEN1%$E7HXC.9E)Y_< V^7OKA=8NVY=H1-KA'5NKID#FD\*)SL6
MJQC*F+E)+%"Z5^:AQ2+(^'&4J3WH#],O?S_E8+I_ZBYYX46*1[&+9??H),$P
M+7X@^H.8MZJ-#FI5F]>MSGZ$>I^VHSDVK3'6;60;,%!AF1$DI9!A(BESH!XB
MHX?L =F342'*V*0VA9FJ4V6 =;#Y)<5F.$CY5/J#$9]YH6QI)AD9IHT.W,\$
M@X=!+!N19^CI-!/UL.!@MF0+\DNVH,G]V*KP<H.-0F=X=/,XO3T?Y.F[C8+(
MHYU&Z-0NJ !I".,&*I[- 'VB!QD-'V*1XA6>A4-2-HK8K&OMR(?A-L!:YES9
MX9P(0END3RV6HK19SB&8<?W.)"_K5N^B_K@%:QX$-U(\KZ#R6+/!64;GIC$>
MH4LZI"!_/\_4 ^D.JE,,AH#ASE2D; P!]@QA"UDCHK X4T541V S0%7,P_WO
M/S;N:@0:-0VHHO"SA62$?QYA574_OQD1CP,^]ZL50]/PR +OV?U+1&XGMND"
M>":F316LN4B#G^Y&=R>VNN3$NWYZ5_CI\<S"4W? I]*?UG"&2[1G5;$>'E)M
M5GAM7=X0(,EB@%?5HZXKA@F6D.?NVS:8D++(6?-T8J"V7).CYOCQQ_FD,]B&
MF6-'#"SE8).1:3PS4?3;N0WPC!0;Y!FK^$5=<OZTU56.N>*PAAVN3 8-W9S9
M\L]@=M;'[!K5"-"F2\Q@S@XOKK)G%KY[RFW/#BY@LGR6%$OE,M+Z?>E?RZB*
MCU$=/*T[F3Z%2_Q+7+.KEZ54K]*9E-[O=BQS;0T"D6(Z!QQ,Y@'RACR$'^;[
M[.C.>7# [0CSR0WPQ4WT %ZRI5+NK#NBU#5YRACV1NHU0(>O2NI;Q7/WBX7-
M?4@M=ER/F$ZBAA'_'9=1;[51=3C2C!DQ.?H.BZ#-+[&!"UQ(8X*[%L6/X00O
M&9.:SY@XQS#.KTNJ$RG8D)1*>J_5'EZ>6=VM&9( X)&BDC#0F_WAO5*P\@H%
MY6 *5NCU*/L],_W6[.^0@G*D6-.PC:2,)$?A9RV*+L?*XPSQ\T02_35(F'N%
MA*E@$M:;5>WH\:ES7E%V2,(4N(Q&7,I"_YR$;@'Q\@!36#O^100P%42],OQY
M;7:,B1Y,.VP^D'P_WRCGT]NFW0)TI.B2:PVEHBMYU7S@8H3_'KR2BP>U;C6.
MKB=G9&LQAE.,LR["\*,5*7XQ]#ZZ@!\_+8ERX*#$0O.F"0X('6$-5:=$&=OT
MF:#K'NQUQ#I$!]_I*!Q2(!+Z"2'Z?O3AR!$A)H<ED^#UX:G:(]>#WA<E=[<%
M'?""BQ0_'V7D-=(06[>#7!K@Z#8'AOYBY&5^^3%.#JS'Z\8VMMYEF)%B/I/+
M2\E<^N?)LI-;^N\?1[*4.[90AVADQ%!$.L<QRCQL;<QR.N$0!I*C[<OSCF7W
M86R!^PFFHSP@$%Q"3('P:&0:(Y.R.*-K3%&7:,8$49[\1S4P4.@H=A$.]:@&
MZT;4 B+81%>)RLX-+#H$#PGKQ!A;V@Q9X-9:O1D?Z@PPN@!9>+OB0&&>PAO#
M)"9B?SD-/4,#T&P02[-0%@=8Z, BX'X1G9A@6.JZ99MC'OV$0Z6X'!?8'A:V
M32ZJ,T<=GL4S5/\0*3]G\F1<YBO:8L2S9%72CE6Y-:D-@L)BNK'N!#Q6L&FI
MI2;CQ\;W1DU[?U+'>RK1-0R-8)T7CWF-3B!*C+OY7#I]O-;P! 2?6Z2?@Q0L
MU(L5&GE.YU@=!$K+&4=EF*YX#LS8.=F!E$/E6@L!1>/0\?"?I3<"XV?OPW=,
MN7N!:QL:58 D>O\*;!D8-&V-XS;-UR;-\_)-:K?2MHK/SQ:U!49@] 1*JW(F
MI7%,DCVBYCN0G0M:.AD7/?]5LN8FJYLF85:$U6;RJ@BV(9K@[*YSGNXZ]J.A
MU]IWHZT<2*R5N?5X_6S9 \QBB@>U5^V=E%9C\D'W<#-)%'W_5;)8"9;%NF6-
MB?FJ1#;SDVZ6/GU5NN]/8KQ#(E>P^_WD,D5BZ0-E,[ET^JZ1R^TE>/<5-M1U
ME5$&(H494G@( :,>T61 ^/$$(X8YKRH(AR!: #8!7=G,?=0WC8D]8!1VS_!5
MTJ.Z.,$73DXRXT8#2QZ.J 1*H0.VT-PQ=W3<S@ &&#!BY__LJ$2P2>[&9&>N
M<.B5^J+YK(QGBX&>>>.[INR6^1<I5H.I'EQ*5/*EO]RAYWRD$Z\%FQ&];/[(
M/S\_?WM*[=2,O(#8ZQ;D-XO-Z[T7M(8E(99T,!SB2NB$[ O]0P/0,*(1Q08-
MTPUNPL86X;T KA/$LZN1E,?GXAX$8P<'ILT8] D%V$Q;=5@2M)@$(G,8!WJ+
M=85YD%CA:4N>%6$74U5LJI8(X1F 46"9X0%V"PQ]"AE'<U[^9DSS6!C! 6*N
M6SSS5/B!+5L]+'KKV8M7;,NOG;X0Y0^_?M%2AUUB%56;"FBGABWK7U0<TC$Q
MDQ34G@V[AG9@O7Y._W'6WG!J$3GCB6N]0+,G PI/%NK_SD(3T!Y8()A]\#"9
M!AEF ?U1+E>KM=K^:U#6'/HYYFX&WA)7A&#OX+QW\55N?B79F;:%,X-EF)$B
MBRR [FW;4!ZC:(1-](RU,4%_)N/L8N);0HI?M)QD366DHWY"^];<_ZA\4:IX
ME,/C;=1<^0"R4N'RQR/NLFR[CLGZJNQOS4[G*M/7;AO;.P-F!F7U #@(IPA8
M(DO%3VLX@<IX1&UPT*[ .R3V[D/0W?EL/^-:H^?:8N"U1L^UQX]TK7$'D>C'
MGZJ[W<L0*S/Z58")SC$,?!JSI!7,+^2(V\Y5D5ZZC.OUFKPJ(\D!.I/E9G+U
M\K)7R$=%]Z;S"@(FP8^Q+@$+!UB..-9>D-D B R-MX+TZM:VU6H/)9+S,&W;
M8K0>3-TF0Q"%I(2JK)*('>D;""/WG I56%J.L@J><*C4-PG/C,;WA-S^"%YB
M:0KR3$7Q@GO=+LI<^2L\0Y*XH1;U%(*&0[Y*4'3 0GA6,"(GCSWE([)T?(BX
MO\)SFYRXUB)!,!J;L(M;!&&7MKZ)6A5O\K/I=IXSPH40#8>\^041?7@K+$#-
M599*PGT8VG<N&::D9%3*'B'G_33P1!%>M,6\Z.45<?>:]YRORU_&P=WN<,CG
M=[-,DI@_"N!51N18;\S331-LLM24Q1">DP$(RDBTA.A1.AU-9:1-$&5)_!H'
M$ [=.A <? 4&K*]O-$_>BPR7-0:RN7A%4>"TR)EUF1: M@(!'*;Z?#6FQ5$+
MA]Q)YL_GHY:8S<]! !.W/8XZT#ZGS@A\ND6\Z>4)8&VA/X_B<NZE(>%0<T%_
M=QWNR&P^Z@@.;"=8L_CRQ7#&1!^T+N'D8D(%Z^8=QUT-7%U8/?OD64H4#:D^
MMH1 2!R[<,C3SN&+^898);X\&:C*@&B]>2*3)\WX[2NA*0TC+DQ$*I6*R9ET
M*IL]% _8O0'PIL6'=BP5%7^)]4WX<8.BP4I 2@@@HO 2Q:XH5[J)M^->M6-2
M,\],>BXF>'G7KI876L%L!I ?R>)BJR0$SR0:9H9B9!KLOJ(--+'&HY'F6M3?
MZE!A[:$08J5P.M#.9!P"\7EF.CP"CX.O,^HU&$![OV%TNSLJ^ 9#V:PWJQN:
M2K1B*<.A%5/Y@G&2HE(F'<U(^4W,T8WN20&_8H]8SGQC@Q0T<8!)8B.:?G/D
M(]F2P0$01I\?X(5#/-V_HLPL>2O419MY\5FU7(%+1Q/XB,B4F JU>/(9V\)N
M+7:*#Z0+JLK/4WQ2O^P-S'4C' */55=FZT3<[0<RS;L%B#;GV8T.W+%LCSI$
MT>5E&<1-X04_V#'M\_D86-O=S%U&AD/K@;L0V2G07!XYT 7[O>^4X%*X%GT_
M=2@K"U@H(.AFT'@[2#&E3#2=D3UJZ4T*H@.^K;&.F7CRD[O<A9\A*GN]P_@\
M413@4LS;7 U^01T/F8BS4SPA])XM^<]\/"^GO2Z2FS8&-\DB3%TD>8&JX>Z8
M? )^;,3] #[V!5&QEPW/;W>$O2Y"\.;_> _8U9U+CP7'C%+V@L3YJP1W6T&^
MY^5?.[%)U@U.UAL9,$4N">8*]5IL@>8;P&(#"=@\'>]O,P^5ZHI)L,4KQL,A
ML/NIS%R%ULRQQF/USL0VD%0Z_T&DNCQWG[396WGZNAOT%JZN6BS.D4!;Y^,)
MQT=P=V[<EMVD#\*MCH<_$ZII8+P5PH()G3#WUU (4=E>Q*0]'<WGY'@V"=M&
M#Z@',8@Z%EORTEX\OW>2^X04; U0CQ"N)](G]LK7F%-GP?TG,AT1G?G%[,8$
M>Q=XE&WP&/"PQAK?U9D3";Z%*RR6B!!=I &T;GGK07R(LPJ0B6$^,B05YQ"!
M(=)WKF&XU\RY^HX,BU@?A*\^[RV H OEXP&B/__R%G^'ST-4)T3DP:T:Z/#<
M>D(25],"U%3HG@31MOSA7.H.OQID#AD3YO1'+^YGGJPEN['4HQJC-:O]&] N
MM0&UN"1F@-:R$[:VQ-NXG"0"N_7$V<-O/,TE7D40)A&JL[3!_/6\0K>"<!1!
MY@8&>@V6\C:Q#(=6T%P6P>#P+0BY]+LI& Z]2L* P(-;QE<P>B^U7L:(] UF
M"%5B*28=B:I@QSD'.@WG'S:4S663\!YQB3KWY=[,2=?M"B:TUUZ%0ZK!BP:Y
MB3?YHKI$% 82L/Q!Y#!I?^  65S[XW&G2=S;?H FN 4L*)N_NPO:J<G\'&H2
M>^9C J<)M[Q$<'F+.\TN3CJ=HY5\G"4]:_,2R;:;O73SBF(MN[TY^M'+_/*?
MMES7Y;#%?5V+N)B\>5W;EFK8\LEMKZNR4%6FJ>XRMU><9O:[!W(R'9531U$Y
MDSG<S?T7V'&V4ERT3>)B)%[M3["4.SI*RF2:CDGW?541QX7Q@0TB7G.,;:!)
M/DG@;;'A=D!MLBO:R[\%[>5UM%_G5V^1_/O1 N:Z_@:LD)+K]:#D=91>34AU
MB3TA1/>'3[")NN>NWHR&RET?;W[L]U OYNG_'DQ=JV ^IFX0\/PR;-V7VJ9_
M-0:7#: 0+R9#=080B_/P"K:Q>/W> 0$'2.55&Q2B*L&K.O]6-<2^5@VISON=
M=WZ]<5]WYCY.3:!\C*Y%<%9@ )R[1\?H;U:GL\>2P56Y]L^QIE)WJQZP[YN]
M!(&.$?LB@P(JF;A+%??+OA@1&P8CC>0K*G1'\9+CQ6'2_]<];NO52WOZDH'Z
M>:/4N6GM])M2'..TT7N$]@AY^6#>9%^X:(J<Q/PNXBNWI*-!]TO5L39#"A[S
M0SF6>G.^U$"DBRS #!H@\*0V*_@:8*WG5ESQC)#3062(6+*'SX?']L P08?5
M'>>P/^SKGE[<+WT." !B%NTT(D=>'+S5E 2KJ+VY9+J(SEO7-TUT6;]BWV2T
MFU<S;X< _^@]($O9HFSRTR;E#?^(S.S+-@K":\ZY7O/K>:S,[A$[FQ5>Q&3S
MZYY[0/:$%A-6 MU1;#Q0F/,6\]=M[EU*]Z.:W ]RX6\8KNP C25J?T1*\QNL
M+^O!CC$H#RCIK;RKU>2E;Q;_%D\6D+O9</8V71.F=<]ZS@QLJON-^S32LW?L
M0PD0.YU\%X=.P?[LJ['7:N05*<I;FF?;TVQ^!?0=5SV]>\OV+G,N\WZ#Y2X)
M1X)];W21?^&Y/=2*&WY+]='9/7^]BWB!ZN+;K<E?T]J#FKSH/Y:^#KXG2NKT
M0;ZUGJ2'9FGV]*UO?:47V;N[BZN_5+DED]27UF?#EC,MX_R,GBNYS(]!Z:$V
MU'"V971_&-;#@%:E[D5:_?JM?GN5,2[)XZTL7_0&W73M[^[TZ"F=>);/SN\>
MSYO?KZ\RM6G&Z"J?[:N;V:#=_S[+/Z9UHWR3[;3+DV2Z>O<C^7#S^;']H%X_
MG0W_OKBNE"6S41WE#%PU4D\M W?-IV2N_O>H\=?7;UGZ]2Y3^7+U^"W_W/K:
M^7S1'71^-%MG%;F:[DO)7"HOV3/;F.#;1@=_GDUR1B]]U3P?3/_JE$Y/!4G^
M#U!+ P04    " "$2K%6VWPE2DP,  "I1@  '    &5A,3<X.# R97@Q,"TQ
M7V=D8W5L='5R92YH=&WM7/]SVC@6_YT9_H=W[+63S$ 2R)=N"<L<"4[*+0$&
MR/8Z-S<[PA:@C;%<V4[*_?7WGF0;DQ"R[4+:YMJ9)MA(>N]]]+[I24KMW?"J
M7<_G:N^L1A-_ _VK#5O#ME6O[9O?^.U^_'7MK-O\ (/AA[;U2V$LO; *Y0,_
MA*&8\0 Z_ [Z<L:\HGE1A %78ES CMBU][G]3F'&U$1X5:"F!Z<0\D]AB;EB
M@J^4F$S#0KUV5K<^3<5(A#C@7KFV?X9L][9!T.9>R%6A_MH;!?[IEHF@6(TK
MJ]/$_T,8=F%@G5_W6\.6-8#>=?_\76-@0>.R;UG48(M"_Q$%H1C/MRQU2F4X
M%0$T9MQS\'\(H<3.=J1$*'#D7J3L*0LX-":*<VJ0S^V$U..UZWR,Y"F!EO0E
M3%XK_7JW" X+N0,L #F&*S:'\DD1*@>5PR)@[]$<F.? B(=WG'MPV83SR TC
MQ>%2R<B'MI@)[%X$AL+=,H>!+94O%0N%]  YX/G<@H-S.?.9-U^F3^-S9D_!
MCV50(!SD4HP%\H6CX" 0(!9,T_79!.6=<L41@1WJB(QZMALYPIN " ,((MOF
M02!5H,=F 74.BOD<RX"1 *8RS.CFMG1=;H?BEKMS37I%GR KP=ZV)QXI)QJV
M?5U&8N_?67VK,2!J18U /&T:'GI>X)#/:9O$>1(>3D<X9>%ZK7RH;4;9M*ID
MH![T&EF,MVY<7QUC%!A\)6]1]0.#8PQ&CZM\;C!E:H$[])2P>:*T_&/$W #^
M_O->Y8V>HD5';,A+%Y'G(.3OF5(,)^#)04[>OGRTUVGTG0BFY%T9N<MT;O %
M>AG%";F,JA+(ZR8'NR&FA\<II2^8G'PN'N7H;9$L)^ AC*4*I\@1A$M1X<7Y
MHD[W/?:DZ;OH]BTS@2BU+;T +24.,^A*=*!!4/A$4AA(T%8\\(TSQRZWW$.,
MXZ"0.*0LG!14A&<TQ&=*N[ XT.CV!/X8PX.\"ZHO#>CR'A"E)A\+3R2H/JKD
M^=R2EB\I)6FTHBB@1RGOE>/Y(3/2.05!BGF%PUVN8P%.A^*^RVP=1G0(I_"/
MN,_A3N"(U-G@CG.[.14W/_>.A?<\>=W3] S<?\ZU8.A-??;A<1&SGM$?B+GV
M7 X-J<,M3@F">XN.C6N@\?F.*0<"/7#@NXAV,7YR!$4?STE?V'(V$IZV,6,U
M$F="82XV$RY3$*++"IB>9NTV<:9B>P.="V@W.T,=&(32OC%!3=J8'*3I)+6A
MA$"K!&I)8K;GK@S(C)OXW5XL[TLSN,H>$8)'#6X1'?*Y];'[A_5MR?H>!FCT
M>T^D3SI(/X,MYG./&R-\CBVR,2;P"TO4VD(I11(@7ZK]'1K[2RRELE?98;L[
MMV(W8S +>\GG?AC,(P9#F+W^Z>TIJ;=>QZ?)-"))B<)](PIHI1]$+"UBQ!-0
MIBK"BJ08DSH1)*M,C:Z'N3E-$Z[TL^1PM*2& )&OK0^\:#:B%12U)D/2"\\E
M6]"VFUB)CTXT]L7+@[]6 0D;P" :!;82OF[6F,D(.60^&J_-1BZG<59);.P9
MK79DB@I_*O\WZL0\X)^XL@6^]O7KE.._'^P=')0?\S>AR6=U6>.%&O&1,>)S
MYHL0O_XO0HF*,@O DZ')5NX(-H>"+*%O$"%-<-W["X099QX:+'I7FM\1#:5U
M8I9H'3J$%[>^.C9IO_7)YMB0!?$:"-@(ETMF"4S5/;V\,LB2_].%BD"'FHRS
MQ-YQAQA@Q6>,/*0'XP@?T4'8)O+Q\1A!?W%@GA@P[Q5J9VR."2_9L!V%QH<Q
M#P.*\4P$H$U.A"M:<B)-[4/Q[=U4X >#Y(BG2UX=@D J@1PQ#2I0"W1\O@QX
M\.) ?;,25 ,+=M$U&AD7J=&]"D_7@2,_+AQ/N5 $JD9?TD?FS##C#C!A,L^+
M<G$Q6R^F*4BFXF%!X,7!_/,:F%'[)N@.%+I0H%3(E,D]A#"*]=FVI7*8EX0L
MPDN02I.&NNQNX2;".,<D=C](=;-U')]E1^K?M59]D.Y0]/0.Q87. &O[K?I_
M7L2F6S+\WTHEN!#<=:I:T%,<XV/$<>J1%)1*\39IK=GZ+>'#C%X*I8]-*GZ8
MT"N-9!C*615.Z-T(-8BK]-T9)M@WN'X]1I8"Z0H'6>@MCZCYS8I?VT>J*Q@8
M*<YN2B-.]<&JWD!*6=!,G:S@B1C]7)(9:/8)&P/'EN?].38?XY?H6SD-JA<%
MA7JK ^];PXXU&( NL'<OEDJG)MM"WSQE5'YE44 IU8--3'0N3N3.%_'19,A"
M97,S%H53#'F4WYF=0'S@0;R-E*Y=Q^CJ0Z (8)M=)DIBMNQA5D-S;U*&C;.V
M!>=6NXUYTGFK<_E+X:"@GWN-9C-Y_FSN[H033JGIP:O4?FC[DOD!ZGGRJ:#5
MLS;L)P30DX>(D)M(@C902%1XV(3S+G'9^:5025EZ+&C0=O!U>WC=M^"RW[WN
M0;MUU1I:31.SALW%J"DBV9?)\#YS*&B77#[6$)Y4'BPZZ2LD>5UO. [J1:#S
MGHY$.7AM_[I>U0/CC_YFA35D5_&^&8$N7!9"^;A<*>)/-)]V9-_,X1Q52?'B
ME\ITCXG4HY$O397FZ-5*@,_J9_/JP^E+/>D33CH=_O#DL?&S6<TJ$O$ E5>K
M<7\"XO5"'_^\DJN.W"N?')?*;\JX$/?@?,H$&AQS_N($K,U'5LFTLD,'UU15
M^)=@\@^!S"&#DVUH8B)X$=Y)S)]_E3&9KRW^4(0NRG\^%7P,EHX1%!"ZXS&:
MOMH&$IE!-N]0U@+Q/?'_7I>F,,CX<XKB.]G5*A5?]/I A!C1Z1'G:K?Z;,+N
MZWB[F:"_X?3Z?KI V617A>@[L6O $3/FA(!YP1;I'9Z<P!5S1$ %S%ON11P'
MF KEP(4KI=HBY6355X3.!TI;RF^V2*P1AE27E]CBBGN3N4AVU_[)4/)DY^8#
MWR(+UHP)%XUFSO\AE>OZ>RZ?,'?3"6E"\HABW7.M>/O65:/5:5I]Z%Y KW%I
M0:LSM#K#5K?3:+<_0-NZ&,)9N]'YM79&9CEH778:.E/4C2^Z_?2P9G^ C^UV
M]_W@>5?*ZQ>SE5/HZB)_4"6:\3;%*?S&W(B^?JZU[D,YEA>O!RN(:.7+"I>(
M=0K#N8_<-Q0;"?L43')!HG<D"5196L,FO>B;_]OU];8-*;4"6#:1 1UM'KZS
M(#WKO"WK^)R5[#=07M G'*@*H#=TUM86=,EQ[7'4314@\KFO5H%XKO/GG7C3
M-=T2K<+O?^E?K95RWMI^B3M;H44I&HL)'<03.E^2CIBJYG-_5I9G G\5VU\X
M#UN_KT KMPWS_/OSJ+K.VR I-3TFPM=EO5"_8+8^_<.ADVXE_G6L-\C@QB5^
M6/S3YRU2A_2]\-[D+@:5V.&L."V2%0IVQ%BOJ -T ?D<;;)G1EJLK;<E^7=5
MNUZN(1Z57Z'CO^AVAEG^2F.&1H-6\02'NFV IF0$*M17G/Q!W&GX]:7,X[<;
M9>-QPUVP\OF%GR<+4E\PY :AUT>W5J/][4.[.0:S6W[FYQGW^%C8@KG0O?,P
M,9X*'Q>4TKZA!.T[!>R;UL45#ON'8OY0S*\_!];,=^4<,X96?'W6UL?%X^SP
M&]/1M$;_?2^*X?5/;]\<'9U2.DI'GX*0F0-HS)N'4_I@(SUF3I^FU_6RY0>J
M45 ;Q=2\2+4'>\KM&^JIVX[D)\P =W4S.4+J\16 ^-R#+C"43#5DZ?RSOC2]
M*'VD%T0>X6+$TZX.C)6<+5V3C \M9XD5T\LZ*[A*^N'  7==<Y1ZP8V^T/AP
MP/2P6>0A((Z^%(/>0Y_)PR_2=SH_3JX(I9T<$2@^84J?5]T1,63+S<R-!T_F
M<RXSMQZ8ER"%H\-.I3:X[M4]I[9/OW=AJ)AC+B+-%T?ZUUR6T,PB<:1.\J<L
M9SC.YVBV.=HJ2XM-2T/LC**0#GI+92:&*&:$TRKB4L5+ZX6&<-=<Z%#\8R3H
M@*B3K"_BB4OF0RI3JUK2&GWO:KZX$4D7+.EHG_ELD_?2KH3'W<$5-_ISJFOF
M5/H.+4W2@_"[Z5X@N-*;<+KTI?<+8T3,*4+3ANAQYN@6WKW97VC7?>6*N5F2
MY3X/"&",A='!A9!D!YN0DE2<1C:W<>CHTSSYFP5+M]A>1@UP4U36;EVL+I0?
MKCJ!V(]<7DJV K);$IGE96'IBVS8RFS%:'Y6[,,D M,N1/PSNPNQ1/\9@=^G
M/S53UW][AOY$S?\ 4$L#!!0    ( (1*L58;?(N0G@L  * _   <    96$Q
M-S@X,#)E>#$P+3)?9V1C=6QT=7)E+FAT;>U;_U/B2A+_G2K^AS[OO2VM EUQ
M==\ACSJ$Z'(/@0)\WM;5U=60##!KR&1G$EWNK[_NF20$1?>;Z*YU5JDDS$SW
M?*:_IU-[-SKOU(N%VCNGT<+_0#^U47O4<>JU/?L?O]U+OJZ=]%KO83AZWW%^
MWYK((*K"_NLP@I&8<PU=?@,#.6=!R=XHP9 K,=G"B3BU_[7SCF'.U%0$5:"A
MKX\AXI^B,O/%%&\I,9U%6_7:2?U5,-;AL?-I)L8BPF5W*[6]$V2^OT&REN:&
M:+@\B+@R>VN<.]T6_HY@U(.AT[P8M$=M9PC]BT'S76/H0.-LX#@T8(-[_A#K
M2$P6&]YU1F4T$QH:<QYX^!M!)'&R&RL1"5RY'RMWQC2'QE1Q3@.*A>V(9KSR
MO8^Q/";0TKF$R2ME;N^4P&,1]X!ID!,X9PO8/RI!Y77EH 0X>[P %G@PYM$-
MYP&<M: 9^U&L.)PI&8?0$7.!TTO <'/7S&/@2A5*Q2(A T .>+&PY* IYR$+
M%JOT:7W.W!F$R1X4" ^Y%!.!?.$JN AHQ((9NB&;XGYG7'%$8)LF(J.!Z\>>
M"*8@(@TZ=EVNM53:K,TT3=:E8H'EP$@!4SEFS'!7^CYW(W'-_84AO6:.SN]@
M=],'G^GR4\@R$KM\YPR<QI"HE0P"R;$9>.AZB4.Q8'02STD$>!S1C$4/2^5=
M:;/"9D0E!_6PW\ACO''E>E:,AR1O*.C[N_L$"R&!^X=0R6O4! 39X)J TT?]
MN&1*,00SP[>OA,M3*>8?8^9K^.6WW<K;EPW<YX3S1N@9&4I&EB_#%6^@P5"<
M@,M)W>>!Q8D(ZL%AB>17\P@F4D4S7 RB%=O\XBQ"MW>),PGYT][ L=CCKET9
M:!30Q-A;R2T6$!0^E62,TR-17(?6I.*4:QX@PHEI3LU"'DXR[2*PAQLR90Q)
M8N[-> )_@D9:WNCJ2P-Z?Q>(4HM/1"!25!^0SV)A14!7Q#(.\&CNL2W&MQ.H
MZ-\][G-CD_% % ]]YAIS;EPIN6%$?@$W E>DR19Y/-W'$W+[=_=0!$\37WV>
MG@7\2^T".L',XI)QT/'X Z)N#(]'BQK'AX>"\%ZC7>(&:KR^8<H#/6,8U>C0
M1[Q+R94GR/ '7G;#E?.Q"(R>6<V1>!8*HZ*Y\)F"")G3S!RTL7IX5HG.@?'*
MQDK.40J&D72OK)N6+KII8!-TWV8$.68K(63*4L7<3?;XTA2MLDN$,NVH[%:V
MV<[VM=BYJQ@8-_Y?,U8UPP!% FWB]LSCHO@4"XFD)1JC*:K7,<L2E@3N?<H8
M5H<BQ%.ATVC20!J@XR:9Q(@^3P972G,%P!R$] R">#XV'%B-037 CRM2;Y0T
MU8=DN(Y,.)HD&1F%5TK3-O6MM"-Q0R6[;7/P+ #^B2M7("LAV80E&6L-BH7U
MYB"R;NZEZM>!U:\F"T6$7_\70<:3G6L(9&2-UPU!YI&C(Q6S:-#9^?[MF&'.
M68!JA89/NTJ,:2ESB/-43-"AO;B0ZXV-!)Q/+L>!3"=A$; Q1E VH*6TVT1<
M%EFR4B9ET,9+Y!()G)U,2 !6?,[(C@4PB?$2-=FU3HE/)@CZBP/ST()YJX(R
MQ_1SS$E_W3BR1@<3B6)A:4I<&5-Z2U&H3K0>[][,!'ZP2(YY%@6;$ JD$L@1
M,Z "C4!+%4K-]8L#]6@MJ!86G&(R+IE4CXH%#%],@28.$V,[XT(1J 9]21^9
M-\>H5V,P8Z^7=9Q2OI!#1Y >Q=T<X<7!_/8!F%'ZIF@.%)I0&"]LH$+B&*DX
MD6?7E<IC :IW%J<($FF24)_=+,U$E(1_Q.Y[J:XVA6-:Q'V22O&_:NWZ,'/A
M?5,Y/#5A6FVO7?_WHU&_O1U<\B_E,IP*[GM50_<8YWV,.1X$+@_E<O)(H=9J
M_YG2MBN6(QGBD$H8I33*8QE%<EZ%([HWQO/D*KMW@D'I%29WA\B&EK[P4&;Z
MJRL:'O,<UO:0ZAH&QHJSJ_*84P)?-0%/QH)AZF@-3\3HUY+,0;-'V%@X-G ,
MF]'*Y";:,TZ+FG!Y:\.68#W-=A<NVZ.N,QR"*8OU3E>J)C:J0AL\8U1Y8;&F
MT.G.4P0T(E[L+Y9^<&SJWD+E8S 61S-T;13'V9@8+[A.ZKA9^CA!DQX!67K7
MEGDI6-FP15X/C16$6^(P:IQT'&@ZG0Y&1<UV]^SWK==;YKK?:+72ZZ_F\49X
MT8R&OOXUTT]ZBL!"C7J4?MHRXE\;#5(":+<CQ,E/]X,ZMI6JR*@%S1YQV?U]
MJY*QE-^]SR?V,1\]DKGHC"X&#IP->A=]Z+3/VR.G9=W3J)5;\MYE4IS6C0Z9
M1XZ[3",)WJ/*G?0PX>6BWO \E!EM8I^NQ-WQ:FWOPK*!?P:;@. AWC>TTU.?
M1;!_N%\IX5_4N4[L7BV@B?*G>.E;-YN,2H3IS:]K(3ZIGRRJ]Y_LYYQ#)JL'
M1VO7?PB=9&;EJR?> VNRWN%O:Q?LRMW]H\/R_MM]N,2HNCEC I6/>=^)[O>*
M3Q?SJ"K\4S#Y03"J7 33)Y6\%(L2O),83/\A$_K/A\A(1#Y"TIP)/@''N!#R
M%[W)!+5?;0*<@[?W@)-;Y.<S-L^YJTM3R4)/%2XH(-C.)[A4KS$IA8@P.*!+
M/->=ZO-#L&>\^3,%%H\4TJS;;$]%:*IQJN:(.O,BP/!D@_0.CH[@G'E"8U[>
MN.9!S'&!F5 >G/I2J@U23E/-$G3?4_2T_W:#Q!I11"5[B3?.>3!=B/2QVC\8
M[CQ]@/:>;Y %9\Z$C^*UX'^7RO?#79]/F?_8T7$JKV_([3]5GCUPSAOM;LL9
M0.\4^HTS!]K=D=,=M7O=1J?S'CK.Z0A..HWN'[43TM]A^ZS;,#&K&7S:&V2M
M6X,A7G8ZO<OAX^7G7U*">#AGKQQ#+S3/UZI$,WF0<0Q_,C^FKY\JI;^[C]4<
M_?4:(B87KYWVNJ,\C.4)FPM_4?T<D&:LQLS/XHXKY6!* 3J&T2+$$0W%QL(]
M!ALG$8A=2=!45I+^=!9]4]LCQNHONB[QG!6P3*U@5>>&U#DY>N= UDJY*75[
M.G?Z*,43TS9!-0[S6.K!RHDIG#[8[?98Y95BX=GJ*T_5WMI-GO5F#V&K\)]O
M_=EX6;Y=IP+R$Y!95J\1FL922H:)E"Q6(".FJL7"#P#0$PG+.D2^6FY^=C!,
M"OYH:/ST<)@P&])2Y'VP/#D:C[CQK?HI<TWO%X=N]K#Z.T[_Q]SD(_N=K37E
M:7+02X?SL_#>XCX&#=;V4PR2]5KE=P/;8F*J-YIL);6 V!5,@VZNCO/C;KEU
MV6B:_?8F$]->,32=73\TS\-X3$U*)E7$8)'Z1ZKPRT^B<+=:]]88CQ^3;P=C
M>6L'U]N[)Q"8M6G'MU/YZ]_>OGES3$:*VC9TQ&SS# L6F(7@!Q=79M0YMWSY
M()=ST LCIB\I4DPM2I1QN#/N7M%,,W@L/Z%YV#'&0XZ1ZZ2S.+$G)JTHVQQH
MI=G2O(FU3'C6O *QP@6F/NE4#R9*SE=>V+!YT JQ4O;*P!JNTGG(D.:^;YM"
M<]PD"=G*>L5"UB@3!PB(9YKJF6_[B?"+[)Z9W_2E)I"R29[0BD^9,KUVVR*!
M;'68;:0.)/C,]E*S( 4*%R\6MBNUX46_'GBU/?J_ R/%S&FVV&+9-/Q #[9A
M%HDC==I_QG*>8SIL/@]]EF68^160B7$<48.J5#8GI3FYS1D1\2G/-7)A,-RQ
M?>**?XP%65\O]3K)P:7G(=5=H<$]F'=R4@;P((1I2S(7X-)#BXE)8M/IOK@R
MGS-9L]VTV^2XPM#'L6,?64H?2H O@RFBC6?$<H@04G8(D>/,,P."8F'U])?2
M=5NXUFWF-@\(8(*%E<'E+N'^35J=_,)=DHC3RK;+G]HY%FF/<GK@+5SVNS+_
MM19K0^[QP=KD9JMCWT#ZX%G[AW)5R$'L\W):B<Q71',=)ULK7^2+M;G2LL%@
M35TY!9F*H,G??!%TA?XS5P;WZ W[NGGEGM[,_Q]02P,$%     @ A$JQ5ES?
M4%RK7   J0(" !L   !E83$W.#@P,F5X-"TQ7V=D8W5L='5R92YH=&WM?7M3
M&UF6Y_^*T'>XZYFJ0+$R!C^JRF67(P3(MGJP8$!436U'QT1*2D&6):4Z,P6F
M/_V>UWUFIA 8/VCHG>TV4NKF?9Q[WN=W7K\??-A_TVR\?M_M[,'_*OS/ZT%O
ML-]]\_H)_R]\^T2^?KUSL/>G.A[\N=_][=$DG1>_JNVM1:$&R2S.53^^4$?I
M+)JW^8.V.HZS9/((?@@_/=2_*^)/Q>-HFIS.?U59<GI6O%*S*#M-X,^M1V]>
M[[SI?CI+ADFAGF]NOWZR _,X#$9P'O]Q/LP7K\J/\.2&Z72\Q@R="<"C6Z\4
M3;'(HGD^2;/9KVJY6,39*,IC^4IF_]<R+Y+)Y:,W_6YO\+Y[I ;O>\?JN+M[
M<M0;_-EL] _PHZ[^I-<]5F_AHS_>]W;?^\\J^'?W?[I'N[WCSLY^5[WO_-Y5
M.]UN7QUUW_6.!]VC[I[Z UY"XRTW\TUWT$Y_#WZ]^[[3?]=5NP<?/O2.CWL'
M?<6O;S:<1]UOW\(/\30[@Z[JX9OV>YW^;E>=',*WG3Y.Z,/A !]]>W3P069R
MU*%/3OI[W=+B.KL#''7[Y;-G;=6!OS]TX;$]M8'/_3@=_W.9OK*/-QOP_(\9
M?=IJXR+@OW9W#X[V>OUW^W^VU8?.GZI_,(!]@%'?TA; BHX/]FFUW<.!.CPY
M.C[I] =J<$ 3AJ=V!SW8.F^NM$*8RJ!RUC0-'#@8K/-[I[=/A^'O0QN?A>WJ
M*!B_?PP_QF]PGL<G.W^#]\/OV_0.;Q)'W?\^Z1W1-(YQD\I;!Q.!<\21:1/H
M*.C(.X>'^[U=F@H?EO.[_<X?QYL!+>$PP?!PY"<T )VM4%J7Y^'^%+:\V8#]
M/MSO[KWKTFQV#_K]+B^29Z-V#OH=];:WUX7'C][)A$_ZM(D'= _V#V #:5 8
M8P=H[ 0(WDYG\UO?UUOE&H^+=$$S,1\,TZ)(9_+9FG,;Q?,BSAZ]Z<SB^3@>
MJV@^5EF<%U$1C[_1=NDI?<>[A>R,;OC![G_A!08>> P,[X_.$=S-0=V4K[UE
M]7M005ZOU(W?L@>GK=*)ZN7Y,IJ/XE_5A^A2_?W'_WCYT\\O7_VCK9YN/7VF
M-H25@JC4#RK\)0I+S4]O;>F5-T@^3(!2<="MS1?)_"HZ^9)O?K>G=I?38IG%
MZEV6+A=J/YDE<'':S48$;SN/QI$:I=DBS:(B2>=JHSB+E=W%W72VB.:7[OZU
MU5F<Q<-+H+0,WIO K(NSJ&C#V6;J-$WY@IY'TV4TG,8P^#Q/QC$/WU8X?!:/
MX@36@<_ER\DD&27Q?'39;,#Y7IPEHS,5P73E+='HXSR]F,;C4YBT>^ \TFF2
M [D#5SB#RQ9G]"L8!J:2%+F"&P*K+9!IY#EL5AZN[SW]REM>LY'D"K8P*:;X
MQGPY_"L>%:I(Z8WPLEFN\KC Y19G:AA/TXLV?KM89J,SN(YJDJ4S>E8VKZVB
M@O[N?H(+F\ 3AUD"A+D1Y6H<3Y(Y3(^&:>%3<Y7,53R9P#MA*LL%G$FL?P<+
M*\Y@=C#P##X_+M+11W6HW_M'E %W*-1&,A]-E^-D?@H[?+GZX5PE<$]@ OC2
M3_#5_#2&U1"7@=V$;<SBQ30:Q<![BV:#=Y?WWFZBC.432530VPN@8ARF(/*&
M><"_HPGL(HWA7=*V&BX+-4\+>6![^]<7+]5B<[;9IGOQ9YI]I'%@7V @WM%%
M(H1+#**\I6W@DW@ZAG#4AG.BT1@O#ZX-"$0MLO0\00F#RTSF+96? 2'FN.TC
MWL2<-I&.P1YOL[&(,B+X6/WGUN;6UM9VQ34R9^!N$TVX>CXXAR7<Y:QFM]4Q
M3<X=;;/9Z'X:Q0M:3 J_RBZ0:O2&\*K::A0MD@)XQ[_@,R;G9,YTI8>&=4^G
MZBPZC^G=LSB: S6Y9 ^_.(8YX\9O_PQ:EOOK),<K1%0%2^(;AK<#CUKN$1 '
M<H^(AUEF28%LQ!!GYS2+B>+:<A,2F$E$!U'!]=OX5<3* =#0)?&585Q<Q/&\
MV7!.BK[ OV5.P2&MG(FWSU^7D7\K 8+O-6_\/X\?J[=)/!W_J@ZC4] YCN-_
M+F,2Q$_5X\=B(+_>Z_WNFZ*LU&P_K=!J?L+/AFD&1V$^VP%>\U%M;[Z 6>;I
M-!G#%,K&[:)P=^3U$WAKQ02&61Q]?#R,@6)AE@N:M3NIGRKFA!.][BN=K7F"
M>\/;<1>IXPH-5#Z;QA-^<7DJ-4;%-G"FUR=O7./*Z*$G;[[R=?H"&MEZ[WU*
M+]Z(6O+NDS<?8I2XR0@Y&_)N%O.T)^JX2N] !@8*U3A!SIMK9<<*_+:Z2(JS
M%,3H%-4\1^>R?]>Q\8U)"Y4?3Q#,@-L.8Z. C)&[.@P4?H9L=0Q/K93L^)X+
M4-!($X!_@[PLB%./XRFP]NQ2;5R<Q2BPU'D2-1N3:)3#?/EY(\A:R/\C=9&A
M1C='10&TJ#8+KQ@7- .EHXA&9R+K4)[F"A@[DIXXSCJXN<C+0^:O-[_9Z-.X
MOC(C$I^7_6.6X\>@)$YE[^!-1D=S]V]3_0'' 1-,YZ";;+?4((M(+]N#'9ND
M4U!06$MS5;S@"%"V(0?+HV3<=C>?A;3L(&SI):D-0BY:XN&.P2'-TB5\!QP[
MFNHG F74*)V*5:MF8RP65[X$A=S,;P;&1+*8)I86YLO9$&EAHGS-!&<.[V*%
MWEO2!2H]J4-50,!HT2_H]?S&9@/_!/-B9)X+%:'.*0CG4YREOQ9/P8*1P48^
M0T("TH+K 9:%56\G*IG-XG$"@TQ!/3B/DBD9+1/0O$ MFK#Z(!L^3L:DG2+A
M32Z];8:WT#:9B3 1L:;C;R N?A:-8T\CBM0N3'(:Y[D= E1#. 31W;R+.FZU
M4.4** &G-D23Z)_+)&/=2Q,'3C7-$F!7</[:B##J&MY<' :IF$G (4C6^4D1
MW<2YC98T"61$YO(RD85K1TYD3A7&IM7!AL"/IU-]HP*2"13/'+2Z9D-/*H>3
M!(XRG;+"+R/4KDO,TQ$2"$XWT1R)N,@<V'K5DS%: /,17DLR,-$+#[,''5^K
MA&QWSD!WQ8?JJ/^:FX6VL[,M: <^MB^1H9N-^FU2M[%+Q+W=F9:/"%1[6-!H
M!"1#FTFG; 442Z1-=4#B@'4O9L])EH-INIT7=5P0GV*>,S=,P]XPV'KV&YS'
MXV:CO(-M[VG>(+KG(/:04WDB)7X,.SLESFB\"\0]R=*;PUQG9O>TLT)SPE!0
M7%, [6@!U-:,6"ZQMDUD"4;(&&8%FB4:]\2;+1,<Z*\[IZ&54CZ$/$;E06T\
MG8]OXQ0J65X@5X\T.]K39!7ZXZI.;B-I66N<F"@^XZ^5[$S4)))1LH#C@LG#
M22!;W(L7:9X4*;QLD($R9@9WW(-[@UU/3KR-X+G.$I1=="N[5JEYZV&6GF;1
M#'45V9=FPY_V*%H*@PBFBKPX19=(H$$@LX[A2J"70EP:\I&O<H#1#GN8B"R)
MM.!K-BS[L;X*S^'C2&!#:HY_RY-"OJ#RR-/,F!UK*)C0GQ;'YHMA-"6&@+P!
ME0UB#+#+,$B6+D_/R!\G)X.CH&8TSJ(+X$FP+[MP3"G(89"CEWD1S]KXR$8"
M9)!,ZLX>!5[I_/%9?.OZY]EF%YC+I8.KF6;&A>?O!C+#O,B6+)A]%T=<S:&"
M[>1+G2+7Y?TD=A(##T&U!?[*\7O@7UF\6!:DFZ0PP3F))=CH+(DS4%+XA=%X
MG*&01?6*E2?6'.B[!2AM(QJ@-*_(E0)MUZDJ/PYY$C^119D\ &>!(L@C6>V"
MU0LC5Q<80_22-:;58H>RKV%:(I=IN83>;-R,TC?5"5Z^U1*Z0O4>HFLM!O51
M2^]F0WO22;L#4H])!29!/03>.V/F(*YJ%BX@2&N4H5"!JM"DD1\/X]BJ:^C7
M3S+Y$7K-9&ABZ;3J4$D'T<"\A57&"AK%ZZ1OM9R(M@T"70$VP!)2[NI25:]&
M@L#!D-#%T@2AU0O54W*0BA<?M?ET/A=-F#8(N:]55OT["+^U6G/4,C*VUF2!
M6P;_@Q$T,6_\B0#;C=C C>;5 QD5;1B393<2Z4?LW5&KB9SFAJU4,GV:+OTP
M7\*1SIWPAF^&RR"++)DC*YQB(&62C&+GGG <HBQHR1+#J:'W.X*MXKM(^C*:
MV'"&R("F[K(SO,S/6FIGF8-M OP&-(A<E$<8&11V?75P&)@<LH'T A>_B.>X
M]JL8[D; .UJ!PKY1H8/J@_X9S:-FPYQDJ,DK3Y&OI01YBG;#M1%AD].L+"S)
M0/+H!2ZB6#PKWK+&%4<6IB_W)C C-:%S2E&9KY'Y,,%\E"6+8!>N_J'A:^*^
M-TI)*0*E%TDA&V!X9W$MJR8ER5-([ O,"T%%H-@^!VMHI!A_7XC?B,=EJ]>G
MX$5TJ;1OGY3^Z%/,CK))C#N,.]ILB",+'J83#?<=7VCLP]!<"\ZL.B2G/3[W
MRY<YM+Y,:Q>)$P:=F&_3S$K"$NV4O6\E!P[%GG+UG[]L/GO1KHF4E2-W]^P4
M1O84 DVMV7@+ABX&_V'+\&7 P<00<U1B/JN>)RS 8$ZFI+V4F36R9S%U4M:"
MZ/,8C$J?CXN8TC9@L^$9@;[>J4H<.[AW^%(V@O#+T-P XK)Z9Z# S--9@AJH
M-DF:#538B('7<N8\M<L*G*I:=J,0&K,KGB@2W3?$"#-4"M'4L Y%$P@U(C\'
MM@9F5 *<.M:^!OU(24[_^L7R=6YIT%N;'_\WWJAK7+V-1&X \'=R4)'+UP:?
M4S&I7)>'#554NRBLV\$Z#@T%:F=00#1)3E[8@BZ:=EQ2QEK)!;_]@];.@'>-
ME^SXWNBT:@T>3XCB6SP*-5-#;WJ@5S<;H%B[NU%[07SG_L8.SV9W"C8[[-IQ
M--71@BH#3%0%=X]]Q2D>Q?@-^]2K-_T53.Y;D=(7"+/?8 9K!=Q?J=\QV^0K
MAM[7WX!R+N):T65XF;-BO=97:G"Y@'5VLFB8C%ZI?C2+>3] $8:E/_6"[_I7
M^,T]2 ^XD_0-+(XGD4Q*,>-JGM!VK4**:9*0/8RS/*5D.='CR64(GPQCD)B3
MMI6G+6/RY6PYPFO!$,6E?(S!8B</.YM&0;S9XV\;KE/;Y,1YSW@>92?^AN'!
MJ$CRB7X+1J!R9*? 9GF2E/Q(*@0O<I%F;OSF*HE BY<Q.;YUE0@QDJC\4IK+
M>F\E(:F]8C#67+RQ\5CB!&QX^@F1)DD!_XU&'L@4<E9-X]-X/M;ZU07%SD%9
MPZ\V7G@1"^UOJ/:G:_]%\"VJ7,IJ7&T5)T1**';1C RT!B855W"3IS48M$@+
MV$?C5%AP:J=-P1QFZ<<XPWN/.82@2U *!DZ0Z1CVX7$Z>;R [8P+[2*!^Y:@
M%_*R99R@1VX>ID^83L1E9WGYN#=G*>WE8K)G89$F\Z+2I9L.X>I&6I>UN@7K
M.:Z>;E2-9B/8BE GER@<YN#.=126AJMV.DC<$I/XT/F_0R&@V:( Y>$LG8M+
MJ&Z>SM$$=@7.U_5*6BUNA9_3,T8"2Z$NTH)7X2)=3L'.$8\O,!E/2TM\$XOU
M1*0+UKG(/O$7F=L\4-J^M<A4[!5TQ(W0!;6A:4FNM4LD%$XHZ:';K>LLVKO:
M45Z5@N >3V 5!FIWH(,^91UTFE[@O5Y?%<6YN*KH&&Q=K7LN0)2E8[J/XIX6
MW97<VC9AE6[T6-5Q>SH0X%?A -HX,#XD.3@:@(Y24GQ&4S*B,<SUA3T67R>!
M]-&;02KNP@+7:K/OX22GT46[BO. L'&HO=+?0.9R-?U5..-B-[/EJDP%BG]$
M0Y ,2PRGDL=];C+LHBGPX2":0KY&HRP 8^-_^QYY3*69 ^<>V02-MN+K02M"
M'@3+C76<U'%%D@>=_%DH*92;<8_1(ANANH1ME[2%Z#3"0"3+<-:+1*)'-D&M
M-!]Y)(^+= )O(,8'&SF-DEF;WK5<4 YVLV&3!RD ) R=1*@,@LKTB+*L@)F#
M%!_K3X*$05>#TS/EQ?B,W64I\J/S).6<%J 8^QKS*8X#-';U"]NL'50<*S\U
M2K+1<I871#3$WV84.K )];0=DJ7F3#L-N+OG"JN(7/F^A<D*,D>_/^I"I^+?
M%)G)\R!.'^I!3K"#;]/E2M]4XM4;1 7M).=J(I<N,,-M98II!)<5I&I,JJ/)
MW(,-QZP8[55_0B/^!1>,=CV#ZQU/*GWQH78RL5Y,$9I7\P8N0J 5KG39*U=B
MA3%\+ZOISGN5K_7F=3P1SQX\$>*)>':?/1%W(DHR=J(DDFP;YMP/++_&@"%P
M/]3& [-1;:#\\)B@CEA4<>%<ZI6%[8(0P+(G$ZIB+HN:ATFX9$8]<+P2>RE(
MI!BK]=P"-TFA65FVU +KKS(UO2HE'V?:)O\Y,.8E3F<6?=1K(ZM#:[%6%N)Z
M8K!?(LD?&<:<W1S(<$EC<$/F]-)+G7:)#Y<3NB68V.94>X5*3AS1>R0+L6I@
MQQSN@TG=)QM&QQ/K39EQS(H-^NM):Z25BR5E$R11H"VG$9R$6]\79F^[GJ"*
MX,UMUD;3?V^OOEU?ZGUV?]5O:J.C/BFPVI^HW7^O%5=SLG)LFW* X]/4(9/\
M:QS^TU(IUN-J;CL@H(O=[O[^86</L41^>[3UB/X^/NSLZK__Z.T-WO_V:'MK
MZX='7Z22#.36X$B/?(Z^F5$TU3L"/T18G->#O97[=9&,B[-?-16\?C+8>[/F
M3V1K.K^M\2.P:%$))!??E;Z0]9)YT+<IV6$VKX>G\F1PA/^%A_1 ,M\AR>RL
M3S*LPAZ/4,+FK".'LMO63^MZ\P<RN!-DL+L^&6A_Y4XR7N&NY,KVXB(E=Z<7
MY3#IAF2,)K.*BCR&$$"O>O@R0K)827&<OY>PNY13/3&UP)9J(9[!-KU",N@X
M[TIRGAD.89Q0GN\XIP0M_(MB'&WV<LV&XBOBTB%<!YS]G J-,$MQZ,_M*>;I
MKGL?[J*+M%>ND\QB!X6#*SQ(W683Q2]_I(('_)&%1>'41]3XV5VU(CGV&>SN
MQDL3"'!,APX&4"NRKB2&$WV,#>@&F!B820I+AB6-\M#K&LBVMLFZQK1W_$K<
M[]5)[_QKV0ZAN0(6BSDN<Z..5PWEEMUVX/<S?  +B?QZ ,(7F:O.9)),$W'7
M>\E=.%VJ/''J\9PR!5M^3;ZNHR5\MOW\.<6JEM-3LH-T-G"XPR45(:C]JB",
M65QH0X_R>?3UKZ<0 W:!%)%71&@26!?&'="V'6)4)9Y@-3@YWVT%$UBLZ7ED
M=H!#LQS*K4SF-P["9L,6=DMU<[I(YF4/J;&3T?.<Q],ZYU]0 5=.*&?W=K[4
MI89:"<=R]J"LKK0KEC#XT.9I&&*,D?[+A^,[%\M)TO8'Q,,I $9[J@UJWE$_
MI5EF1TED*=TZB<OGG&:(UG8699<5Y0WCKPU+\JW].;'UY^PE^6)92")KL]'S
M[TN$SAO\7BK2*5 7.U$,?6!!2;P$WB.XOV=P#9,1C#@=+?W"VMH$4JQ'LHGN
MJ_S*:^$W6$N[LF#21,HY>N;%'CCH63]1O K(:I#J9*> :_OEE];_09??A"TL
M#^.0IVRTS>N/\W1Z3I(-[F*-5-I^?O=)]]9=Z\\?7.OB6G_^X%K_SEGQQ++B
M?0=G!D.UFJ>R&[PK$'-2<M!/"V0$&&O5<'4<YA3^9<2=]9H'4&5M50%<)D@8
M(H]12%/(6./;D=3VP\3"B LO?6$#;:-T/KWT/V^5E <=9)Z08A)IS3+G;""8
MRCQ&C$.8&F(<7LP%; ^-+/C-\\V7+W_ Y$8I C>H,HAD9K)17#O00[* %VLL
MO[9ZB6.URK(I]%@U&Y(HLRSLYE-"W2FG[ F:1,4+ZQ(Q4'N:7H:U&ZM"L' J
M!H502U8^X5I!\0S4'+VZ[9?/GI-2?>V82(A1\"'ZE,R6LV;C$*8'#\#]]8$4
M_+064@J&Z7E\BS447\,DK7F'D]Q!9@[^N%)%TA!-%3?.OVTJO&P;YTG^^$=0
M;J/S^-7C<RS>EUR+=$Y>''BHO7*$W!XH7* R$%7-#>22WU3#BI*.X@Q%DR<U
M;>7L"5XPQ2L"2PW'J)A.BP?VZM7H9T)HRM*9J^?11)PHE)@5PRA/;("!8%2H
M()HR2<,XVR35FYISAJNY<791-877(&S%4H$S'\(&%I<>L)4[@D<"I9KK193A
M62_.7* :\C"Y"%/&J.97V6H8\1])%K(W7D6R%&Y&3CI!4299<ZSR#O=DZ2,N
M4:07AV6*YJUT,)J%TWEG^5FR,!6GWEL%H\T:"OF5ZGVX*._',)N%H1:2'OSV
ME@M"8$CFVKQ3F\?9<AKK2/6I>;GKTR@L#E2S,?!.JKQE3B7Q;#$EKBNST\X_
M&T$F/R,ZOB@-G/!W4LP;O PS]DIO(9L:5IO1QOD3T,4".H^>)7Q+&($XED!J
MZ PP#((35'%>F*P\$GTP<ZI,KKB[EBJ<@W&.5H?XK?;",GR&=KTH0E2LO5S(
M)H'I'Z->@#J/@()D.D<+]GN!(A9%=.P(:)>SN"+,F0@[&5P(P+)"%9X=WLY+
MQB:#-^"D3-U8V=\V.-.H%A5*AJ$%^$TV)@_FI=V[+*FZ<R$<$IT8ZG640%G%
M%O!6B<Z82TZ!S(A+*V"$O]),. U*"3_![JW0"]@+F)3HH!<[V#P:>A"K1#+@
M!358/67S7)<R:!^_#YT@D%,TYO12%R_@RQQ=6&>6>GI=D(N-4[,:75LY50B8
M/YD52P88I(M!&J65%<P<*WA].G'%M//858(:KDX:E(N4.:&;7-HNBQ(M8_"6
M."-7.U56:GUWW\5P+9/LU)ID1W$>9^<Z=;9.@W^E>G,#QD[026=P7?[%( U9
M'#YN$Z9\2D_F< !$QAF]-D:*-(J9&52G6EL<B"JCXCIE3$^WMDQ)[4QX]96_
MME8+.\E*9@OR5ZK<\O >*ZIFG-3UFG>Y";8!<Q..6S"($$.E?XSCA=Y#CK89
M*ZP,-O(E=BJH,KK*P%M[I];?J'MV9<_LE?W[D1S\/[X!0/*WQ!M_NFGVH+/W
MMY/C 78%:C8.WMK./(='O=TN=?+IGWS8Z1XY:-+J^'WGJ'ML>5/@T<=[5^L'
M7R];'!A7%M< D7"=(P;I)4^=X)5<L&4O9O/T[M/WK7N]7SQXO<7K_>+!Z_V=
M\VL'R%T*3O9T)@QQFN/%%)0>9D9_A.GBK(+K*B]@,IHK/&\'9:)!*Y6@9G[L
MI#!8_1?LP(I>&H2J2K730>8.C3HG97Z&6+&C:92+*P35MM"P**&-66,>3=N<
M(ZY@S@^7HG1R@A$-2_8$=R"167#22F[ N;B^J;+<G/(R),EHC%D'0P;_8A4U
MQPUO!VNC4C;=\<36C[FH\NNO_!N0V:W#]5SGY5_6\^R1$5F+D9K"KS -XRIM
MEN%A@1HXPPQ)'HG!R3?#@T?;-A:"(.H(&PK<E.AEMOD,ZQ#+TR4[*T1*D-9.
MD79$CS0(8:"E&'^)7PH=&0 _Z] 6;P!VUTHSU]&BG036X"OOH+,V%ZA'\*(Y
MR9!2 CT?.H<&"#&H[J7K1IP\['WB:/:EFZJ#^3!6N2IAYIOJZ=8*_R-AKMH>
M0LX;09$S3%1@6(F7:KR%DB^9J$@[N0RJK%.*(AD0FJ5F'A-DHR_RUZ27PXY,
M6PUNJ?LF*W.D@_W>JTQWTC2#)$W,GIDXV:!<&"EI7,[,'1/43BT=@?S)I=2>
MG>J<G\<I)O-2SPDO[N<WO)+.34'&C8\X'EP7DYH:+=!7FLENT E-J'[((:\[
MKWK?%*>Q8PZQV2#<XYX3W"U[>'J3MGN@1X+6 KM\R&=[[>BK[Q]E"LT)TO_8
M1G+> CTR-,,-QN>*MG+IOVM[*4J-)O1FC="LX=IJY]*VND99(#F0+W[(/#.H
M/#[[O9" P%D\)?X._]2\1U!(# Z/;%9+.SYQ3.PM2B$";PV$.>(_Q1 RD=^(
M$6]FC5P(@N- B\ 3]&K*#5:<MAX"?K->FYEZ4%UV#IE],VO46TKZ&WVW4<4/
M"J^'(IXS7/\X$SP2"7TZ761L:F]Y<1M>/JER2_[VDND2.:O=G%)3@WF=A-._
M-7>O7;57P4*<G+KQ<D0X?SY*,P9N1QB_<( X^43J#YLNUZKP(6] 4/SX;US1
MV#U\JGY3W<-M]0D+&O\O%S32OW8K6L?>^C1<-#4?&'#G"-Z]5M'A0\WA=UHY
M]!DUA]<'#@][MSU4E]T)&KE&D>&:=:D6F,Q!7M?Q)')XFW*5DF!"7Y3\ E5X
M3Y($ 2(C]H%Y/M#:G:"U:U0RKDEKT:A84O3W>F3V0"]W@E[@9J]/,=?3_*,'
MHKBS1/'TYD2QIGWTRI0CM=59>H%^7<&>I><7CB/(;5LSC,-2YF9CA>%[*U7.
M:LTB9VZLF<R]KJ9OIVF:^>BMK[Y0$?3U"/X+OVV=T/!/#Z%A"0W_=)]#P]^
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M)GG!"6&>? 3S%T4 J)4YE\.A"30W9I[U0FNVMS*#A3-1G7W3[$G/&T-7R22
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M]2HW4N<5GN%"-YZ%Y*1MO6IRKJ=F21O@"\$,EF_P>E1E+J&/QBW-F/2<*R^
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M#P[92^E9Q].Q?G2>#[^0PJDI L^.9#@;_#5BP?N>0N?\1-LIPL!P=SE*NR*
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MAW._DY1S#E9\X>"/?LG?7_?>').6CY6,%!5X2[60^>LGO3?_^":AIQU9NMZ
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MLO#1*FZ%(TR].5W!6,L.+M$B&4:&-72SV1CXQ&AD.!J#F!S<ZZ&77B)-OPZ
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M_XN\\D\2\I1U4243,_*Q<(V&G R%"4 RN$]P;G3,IEQ,S1ZU: /*LKF$<+M
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M!,8,,J=%^&D59.NY!PP:Q9+6SJ?ML@*'B[AR#I]-C9B*8J@HZ"9MODS6V+M
ML"Z;L5B<B4&'O_"R_-0(K1"85H1G%#<;(WA4FWLU@.A8V*:)T:OX^@4[ZP#W
MDBN)K 6(#$MOM93F".2M LJ$' ;>0]GLDJ7 HI48EU%<KI\.D_@:'PN2O'R7
M?SF/G%(GB1 0_ZYA!,R<\Q5\-3EO-MA&K(L6LB!8=>$9JA.L^6MQM.CY,[+V
MUG8NV%AJYUA?BG7 6,1+Z>HL0)7EV#2A^3A(8!47,+>P^BF*T[,(#858X-4'
MP(D*53!"$8C+1"V.X,;HFVYU(-]Q0A5J>NEI%@CORVU("A*3U.R&8W.!+"%-
MI#%8U6P\2R(V?Q9651#>O-%5@)LH$%;C-':&!#;?;,#E#^/HPL=Z8CCO"+@\
MK<%3*"HD6.T1Z;MK+XV%X&^@ (F4&+[E>'.!)2R!^('V!Q;0STGJ,4ML-HR'
MP14<;Z*[3AQLU22LCX7SG%+&%DL$ADA >>F'[X_00E-;560:5#E!@(ZPEG22
MLMQ7Y4NL%G(6NX?9Q7FQOO9R?6U_U6TD'I- M$QTU\Z/0"X)Y-KY$<AU&RS^
M8<DUEMSM92VY8I4Y1:W]Z1Y<$9UCZ5+A#22P#VK;?6 M;OO.++M?;L95.2LN
MAB;<QHQK31%!,IR%7I*++BG42B;^V"I)BHXE0'@AZT[1\NR12OT+',3.AN(I
M+JP.<"F9@4S);PI$R0$L9XUI-EAT+HA0:S;VK$K-]'*Q4<7X!^+<6\^>DWHW
M"UD#R)M?.=?9".N'E%]W^'1'&X91P[H"@$AXSO?$^O$6W;4M1*N*%29B%W=J
M#2+;HA])Q"4H=[.L($\_M%UD\B7FD*[$\EWINTC1.XB_','BWI]\4P+>MJ@B
M; 3(L-/".ZL8Q[/,: ,U@*?%HHV:J"/=NIU--EUJHVK$ANE<?JI9G[8K.N:9
M!<K6ANI1)!./*&,53Q(O=1"QX@,:"*N92.$HLG.A&IZG)<T&VV-I05QQ<1D&
M0,2U.O-N"5[ 1H2\=0+#DBNG,O%LNBRX\061D?[IP&'W4M$Y%Y4I!B[8-D )
M3SE_9BWM>2%G'YRIL0$X3A<'8"875 X(ZV]G:)3!=!D*_8L7>Y8V,"Q&PD>)
MCE]SDP'3CB3O1C.]D5KLD;&!;:@)8]LATQ#$A-)E1/G<>$O/&-NJ\Q>+ZJ@4
MLB@IS'R';M*831D,UN"U+R4_M9S5E^BMY7#MVRNN!X^ >WV#(O_G"/S/EP["
M.:X(8TV%%G:IP-ECB,FYQW"1YXYH?XI^1LSS,#5[@ KF\E^ PQA_+E,Z&QA:
M:&*RXTH6-?&?Y0Y%B8X.1GK6;!2[7)59.@L;=KE. +CX6>55LHZU=$.9&ROI
MCBE; $A &+)X@+[E8BW=7"N(NF5P'#JZ'ZFO0CK#?(Q 0BZU8%5H\:#C.)S0
M<31_&D#EG<L.U$&B4PAXM[E/E<V=,;[4J<(DVG C! !)<H$,J3KZ>]QL%".]
M*_LO"9?Q)D9@DWDJ8[[SCQ0BP)>HOUP=]^VEKO>^:IGH=.9X C^J1LEO.-K[
MN:.;',4I,,A]FX<K.C[>'"W:%)N C$VXMPU1CA/R) 3F2,,XY>CG<8;I.9C:
M*X',F-@!PJ119*L%&;I%\*WC",Q-AGN:1+QH&9:$#MB/A"M07M2HZEI4I#T4
M\-XN(Y_A0.J9D5M19-^@'&I.*ZBZ.+D$$WL'"XVB.(':!9F%$85SN! TPCVW
MCL,[BYU7Y \4^A, $A8F%^<=P4=Z(XA=P776_0@F?@@YYL72<DS;M"1\%$'$
M]TBI7C@"BP,%"OTJ<U%U?$.:D$U=J7AY,<.I#F-L-FK+U-3TE"QW-_5T:T4)
M<-)]XKZR,C'+JS4O<L'#TM'J(""6,DI?J]XT!#9R/I6LXRY68<H[Y$UQ)O)X
MYH34G-)9[HBXL6,3 *7G7N[<@=8ZEIX:)* >DT-D3+J.!<51J)'LP<WVRP=)
M)/(X[7 V-2/;[]EFFX+&'GI)LT&B+S?^-*VO7/XC 9A:^OO,/#F#LW9;*$BC
M92J1QIS2;%8_@-_?#*F6N5B%^V8FM'-PK,#(EP5\$^+7<C[@9S]\P.(#?O;#
M!_Q(Z+-5$-J2A,N":!4_O5<"[5(="JZI(="&D$BA(9@/+X%8_X?Q9!!$1G%(
M,,(=]#ZK3(S520)3H$51:A<5:;-R2;-Q".9U@[LESG9+.>)L&H'K[RFDLDR<
M;T^,#3?XAHHNU2&\+5]XYIO^<26$9XO2F1\G%UX4_$>PR<^&ID,IE<L0/U@9
MK1#5W'>-0?I&5@I+L=Y<3TG&K W,J[A)$A#)W\1)Y1/;Q1;1K$=[Q#.H4R@A
M=*IUQV;#5'HGG,MS>[;=D?W= 0,7KTY\4E@=*X W\<(+^$?_G;NCQ6A4778B
MB"A9@8#1; SC!#"67UC+ R@_6++<*DQD;RX4,167 CG3V EJIZ7@5"[6$?ML
M5++%1>X:"]9K8>QAHA #\<J?DSO# BJW8'3_82BB\97@M?<3^[>)N4S)2P?/
M)GXVE\!C7*!T5R]\GW/=-AMT8)7 ' 4I',V5/\J%8]0:9ZOB-)BP,M-9L[DG
MOFWPIMV%QLR8K^A;,=&ZV_U-=V"WKVE*;NJ7HH735J@HT%2M 1@R#D2YJD(Q
ME^\VG$1]#"*V%'D3:L4K>2;D&<QK"$XN3F*/<,WT;*=&P.NR(5H+[@E8)ON4
M\SC9*F!D:ZGKTBK=6OJ$8.?),<^XEH*II:3K:G!5&N78O5O,J5UT6()G%G V
M'F1>$)GMWGSJ-Y[+:ZXR4$/1O3"-Y;Y+BH!09F[&OCB8NMP9X!9$FR4/B7*P
M]@7#S"G-R7$<U#.(5O4Z'-; @D.YE0&-L6.M*F6/;_4;FM&?[_)R1:1"FC+%
M=#X^ $QCH#H*1:BG172%#_AZY/$U+2)L6L98?)5=P_IFF;)(WTLC9R,#/5/F
MN Z!:&&YD P]A'T;)[9AD8+$?B>-#FA]6%?Q"ZM76>:6-\F34IDR8R>?OJV[
M9N=-I<FD9FBG\ H3I(LD9D,*?P0/ZN[<E"E8^;0WI.2?5$VPU3A)#,\W?[J-
M,+:&?-[26MQ'[I)?@IJH_2;%-;A_8[K"1_)7<,$VQ/V6N*'B84!1=_C7&*."
MZ"^$0\N.VVS4#Z3SJAS=PN=,,9/R0$LQF4:.6K1>2E]J 47'<N;AG&40_1>5
MBHLC%C\(H)Q6.LJ?GR^")()JXB<7G/-T:YE/X-:RV4REY=%"W/6Y4W.Y.$S^
MP1^<<=7*%R S_,B1I0RL"G7A) ^^(!A18!1P%IPS37UF#92KP97^$DFAK0)4
M2]>K@<7R%EQPVW.D&)86NJ6878X9H*85"'^R!K>!T:3HQ$L*$%WG9%HI@)8+
M(V0IS@G$RJ%Z*65?2C7ZN@2765*&:6.U2ONX0K9ID123DW"0%YF482XD:</5
MG#72A1:$K+W8)04/H7]U*[172V/]34(7X2T\Y$T#(+L%W:!._.%06SRW&8@B
M6"N9^Q)KF)?/4?:6LY88LP6F:R'6)]+>!2L#VA,<+7E(G&YXAW!$34^G>:?&
MWGY;FN9(QRT3]D#!<7(>7DD,+AY'"]!W&D1PN>C:#R]]CG,@/G=!:UB7\.J;
M.=4:A6&ZU2(<MJL<KILOT"$6)Q:S29P>I&0JS6X6=V^,@'>4H)8-%2TQ=#**
MD:$ -#W*>;6QGJ:8IX3?4(,B65=MFY9XR%'[0VM;J %&M3&M;*K1%X<%R9A(
M$3/^H@H?)P7.0W4;@TQK_NDLN>*@4.<M-J=Q;N*(^ 'ZVS%'(01Y!A%.&MD$
M &I!/R<J%=M(. _NNP_FRH(X"EQ5S$ -D(C>>T(/EU:FW!Z/-6*<G"2[MVHU
MIUKQ414[I)DZBQI%^'AUSY4<#:RS6SKU)I'[DC(D>9:..@'28RW$U8#LJJ+S
M6]V[_@6#Y$%D*H;$"]H?FGSL.M!8\VP^5L6;.OWB2WYK&)_#J1:L-"*L,54%
M066(*)UD3+5S=+0N5\&[<KK8LP2"8@22%F0QL#LI^KEP2G0)+!07.!"=&-=E
M3/M(*=V<+MLBYJ\+ DDE2-K:(C(1E<F=B8,W1AQW#6PT6@#,3,^>*D. ;Z2Z
MCDZSZ-)69,T#XS-I\Y:2B?UNT?9K39FHN%BBAGPZ3Y5Z9I8.S>(2(_(#@P@S
MFW 1!,D)<1(!;,!1J9[ @MX^+5T[HE#L5U?=B8H=[BHC+SR-.\:26=Q+ODRI
M9V+\;>>)@B2O?3U!9",[Y0F==5&Y%%O@TR&7G%H&+ 3I1<QB:!5)%HE#6_R$
MT)?VLA9S,770]HCUTZ=P1$[:E:V9[-P_8H',3RA)/&<?7 *7:RE][O;I6@ D
M"=E1N0$<@X<*7TH&0H&NY<J LQ9; YXURF)BU9?UQ"'UJ%,N37.\%B5XN +R
MHAT9\IQW@-2LJY4K-)R74O(;,%G[!1AQHSIM;1:6B2,!,<R8<+.!6E<L=[98
MR;N+S)HNLS@V6+36B84+H+ NH:%ED<TP\H5B6PF+A<H1;2.>S;2 XZ<DI)'5
MCK4T9L\4EQMW"J7;FDPW+Z B*:5L$M9'S1*\BP0'\9#H!/:RP0+"3ME8(:$F
M 8ASC9CIT,-$9GS/Q%\78;'.6\<X>8T+%  $2AV+YE1O/+XFA,K;T&Q%;Z'.
M2Y'DUL)^:SD@Y$05!PI.AIXI"H2<-*BC6I?>B+4$C!"G,%AW'QP(]_"I-H^J
M1L3S'_%!$A_T_$=\T*/$8G0>/#>^@WV2U+BR%R:%D\FC0%VTSRA(6;"J>$1%
MR!"DZ*.V/PU\EH>%X508N:I;;K_0U>"0JI5SP@+*!G-+#,K(2(REX9DF<C6A
MP_3=31HVL!8NBT!CCDQ;E_*"HD!$4%E:<8NJK6U>K#4X+76D>T'>D4KZJK#J
MR+\NRZRIHQ&2PBCUT5#]0E6<?'$:++F"G+;O[[5'9>:CN4[;Y,*2CGN290::
M8FPJKCDA8SJ-@PR:;);3053?BSO.A+[;&+R>$87*YU89>72C6Z6U=$A,M4^&
M;<.MR@"3NPC$80UAR8@:#GS1;H_E0VD8T>S"D1(Y5<[**Z_P,1=7K@M^5:48
MY;5:3-H!#<@72;5"S\)<;Q;SI?Z<->=56V7)XI$+D(QU(Z4"0):-J!$ZE0^L
M(>@L"I]IY75)6\N@VAQ=$?125ELQ&ZP8^4("L;8-%379\AD2.)8Y1 E%N:7U
MM'!3K#&U<NO-QH3@;NWF-@VQWK!:B+99;C/%2!NI'>&B7VTBBU0<8..%S<#1
M.S.) TB[,('*] !RGBVVOZH.#'$*I'B#^,I1U>J#26PTPA*!)(7 CSI:))6&
MW+"1C?M)%GA(9F/C7SOH$8MLP/=APEH?G&T7Y7L_S9Q^@ M+=%-&*,HO;J-7
MIPTL63@2[2M=(#65P_'DLI4)2A1K2V]0LY9TF 13CI.8LXD9<#(,_)GFGF.[
MXT#ON 7#83U4;7;A2AXFA!*3Z<F4A1$Q6$RF8@A[6WP!,3.;!(B>B2+1+U)V
M4 (<\#IJ:2V9.#R5MQSX+7W1(A]!AB9'S)Z_F4A5^6^%ADHP(<MNWT@"SJ\;
M3F WELD5Q$;6<110KG =,LM1<IF4A%YF?O[1]Z>ZIU-(K!7!3-$>L^PR3H+_
MP,'FHPHDFKI@SJ/[923SY>RO-9;%SS]HA<VU+"'/.6]S5T[+X3E0831CI-M1
MF#+4< U:R]J3G2YZIJA.0<>BF0%VK:J"+?@\.@LYC7(PY^84-5"I%"/*#FOJ
M"\@KL.D7,ZEQ?04X-C*:64N-9ZBG3;V A9@HCIYBU$^:&B,[DD4G#6:*FMN4
M*Q_Q$6C[J2W'+.5]C3 Q2T3.K@'W9T!;$Z^"X=D"V\*Q[%U?$I#JKN&(IN);
M K*=4BU@IJ+U$>9Y(;FJ;( NK4[%A6!7J)]C=*IQK9;*K2_ Q#RL;CXX%N/#
M@%S;:PX0J.4K57)Q:DT)35E7%*,,C-D3;N3V[!.?6HJN)&Y5:5J1F633D_[^
M_]E3[[WDHY_I:"/KB/Q[%HN2GLYA81.<#PNY:+_C@KW;.B32/%=L(2>Z-M.$
MDULC9]M2*05G12 $8Z'1JR[.])BR15_\L :+-?C%#VOPCR(;-Q39>+ETD0TL
M@8-- Z1YT!FK#?=0=.,A];Z73B$&-DOIPH7-QID.!SR3G"C=QTP*_ETBD9:R
MB6X;752DV;,'?V@?J9$F=4W-7,#A5<R-+:@5@_35-L8DP]<\$_DIAADM35.!
M4;$3<%AIG*2:6;&0,L%2JHE$UJ/-1>M;(C=<@PB5QOX5%X_*3Z-3R4QO"\Q\
M,.U&W!2(7$1C*1FMPLPOSH,@<<+?I,02#7%%]I,1MMT(!N0O*+LV7KJ9.M($
M JWLNFI$(;P6-084L7CL*C$'PZ.*)4NU 8]+L>5:U?FF(F9N^V34'P>?;*TC
M%-O%4Y_WV@_#.-5ZM:F"QIVK"\%)<CD/J$Z5$R2I,2$7-FBTB5R7$[<- Z=-
M2]4.#%#& G>#F<X1QSCH5*=,VKCZ0NX=QBF@18%.FM&I99(L0^E3QA@>F685
M4O+5ILAA,@)0'&W8NP[8),!6 #3@Y0N^BKEKZ@^QU8[.Z:L#,!D/&,@&*'E
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MW4.(4H<P(%<WSEH$Z4((/+LD=(Q;,3TW9RZ03). PZCSJ28F8E(;($S2>]7
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M]YV#:S9L-(_U3)/)E@H* '/FG]5V>-/@(!]D"YBG2^JH]H4?#><V?,DZC$=
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M_YWOH0O2O=F7\E'Y/F!6DRE4C7DACAN<O*Y1H.MV4&D*_*/E. *XNBE=@6O
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MZ+P#DN-^I_M[YZ#EA*(X_U'64+,AOMO4QZZ'@J:47J1!-(M$+:[TW>9&_)*
M#<S/7C9BHZ5\RCH<VO,NB2-<&%72F@=.9'9.>:?:3[)1;J:,FVPV%G1/?<1Z
M'X<>C=S8(PH]>LPK_@JTTA5KH-^VGE!#66^K+F"E<*,OJ =7%YH-K2^H1>J"
M_=_CPY+Z :O$]9L4 [:$WUD_BB>[6]LN$.\BT4CO\Y>]DX,/:$3_Y5W__='N
M_P=02P,$%     @ A$JQ5B 03!0I P  J L  !    !G9&,M,C R,S U,38N
M>'-DM55M4QHQ$/[<SO0_I/>U<X2#T0J"CN*H=+!UI%KQ2R?D]B#CD9Q)3L!?
MW^1>> >!MO<IV7V>9W>3W5SM=#0(T2M(Q02O.UZAZ"#@5/B,]^K.?=L]:S>:
M30>=GGSZB,Q7^^RZZ))!Z%?1A:!NDP?B&'TG ZBB*^ @B1;R&#V0,+86<<E"
MD*@A!E$(&HPCC51%!P7OB"#7W4+W ;@OY/U=<Z+;USI258R'PV&!BU<R%/)9
M%:@8;"?8UD3':J)6'!6S;SOZ#5-T0L8OT9/Z.KICCSW@1_%YY[&C?I$O9PUR
MJ\??O!%TGD?Q5:4< '^Y'G=D\'2.WQIOC>=Q_XH2<9V&K"G:AP%!YC*XJCNV
MOJR\8;D@9 ^7BD4//]ZTV@G.28'54<CX\RJX5ZE4<.+-H4O(45>&N7096W>7
M*)@H&R_;@&=<:<+I'-[7$\(L^ "GSCDH6PD]3*$LA_JP@%- "SWQBHW#X$OE
M'!@KMT=(- $'1'43T<PQ!U92+P.-<1'DZG$$:B4T=<T1KBX:$RBEG&J@?=N2
M":AXX!V:P0IA %Q?"CFX@(#$H<GC)28A"QCX#M)$]D#;'E,1H?".6MZHA'-A
M^MD,56:QMBABIF&-X4/-WFQ5BA!^FI2179A)6JUMG;@AS&O@(.;7G71I58QF
MHN-#P#A+@F4CXR'7#DAL"S/+A%+#B^ 9B5B!_X.?).M(@C*\)/N6,63$#+*&
M1$E(XW WSC25E93,D)_2]-SRL;B# "7C5+477W<4LP^:D]GZ$H*ZT_.IF]_.
M;U-9P?1%CK#*&Z8I.?C%P\CBYA)$TB65I6DW(B("J9EISIF13C-GVM)O9\(@
M&T<Y"/^#BD/2W;5B0X'P/Y;:LOJS-6;C@:?SD>T79ZAFJA52([XTC)N>PO01
M;PF:2&V@V)V;\UQK<KV26_8*(^5/,]TEB>D)[)9$SMLCB34/\JKX:AW<+I(6
MVC;HFH=]8]"5' RA5KEE[Q1F?P-_D4,BLU,2<]?I:XFMA!4MND7/+7GKTWF/
MF>S57DU 1<RU'._2"+.4?+/?;4Q_X-M=1(Y/+\'^T_<-NT<7+ =?U0(UG*J9
MY1]02P,$%     @ A$JQ5BT:84O^"@  @(8  !0   !G9&,M,C R,S U,39?
M;&%B+GAM;,V=76_CN!6&[POT/[#N30N,XW&"+9KL9!<93[(P-INDL6>V[:)8
MT!+C"*')@)(3^]^7E$19HG@D)45)SL6,1WP/]5)\3%)?QY]^W&TH>B$B33@[
M'TV//HX081&/$[8^'WU=C"\6L_E\A-(,LQA3SLCYB/'1CS_\\0](_OGTI_$8
M726$QF?H"X_&<_; OT<W>$/.T$^$$8$S+KY'WS#=JBW\*J%$H!G?/%.2$5E0
M[/@,?7<T_3M&X_& >K\1%G/Q]7Y>U?N89<_IV63R^OIZQ/@+?N7B*3V*^&98
MA8L,9]NTJNWC[F/YIPC_1!/V=*;^6N&4('F\6'JV2Y/SD=ION=O7DR,NUI/C
MCQ^GDW_^<KV('LD&CQ.FCEM$1CI*U6*+FYZ>GD[R4BUM*7<K0?4^3B;:3E6S
M+$TZ]#4G:7*6YO:N>82SO-M[=X- A?K?6,O&:M-X>CP^F1[MTGBD#WY^! 6G
MY)X\H+R99]G^6:*4)HJ$4;GM49 'NQDJQ$3%3QA9XXS$:D>G:D?3OZD=_;G<
M?(U7A(Z04DH^P':=-NHJ@R:NS=X1D?#XDKW/M1GMR;[\[HCL?VA /=YY$Y8\
MP_1=YNN1SFW?D/<=\4.<^R,MQWGROB-=B_R_V,[:EM]\>.W'E:J-U_)3PR+9
M97("([$VJ:KH&('S/>030UEW53N/&O52-9IST6Z[FAGS.E,2':WYRR0FB:S[
M^$1]&*L/>;/E?WZ?<;D2N%BEF<!1IFO*FW$^LI1/3$M*>2&T+RRBGL:5BDG$
MY=3TG(UI<1B+\ ?!-];=EJWFEL+?Z:J*+PZ+W 5@M"$3).5;$9$W]4K=+724
M2D<;*A5J2478^.MB]$.N0;]IU7\^30ZU..AHN03:;@C+EK)&2PN:Q:ZZV69*
M]W*]+(A.MA@R^UA+D-(X[N +N>-8[?R*XK7%OE'NJHNMMG0?-PJ#Z&2;([.7
M*PU2(E_=_(6DD4B>U7*^JQT-F?-.MYAL]7U-$Q8";6,P"36MIX']GJP3-;4H
M"^K\EJB-'<,8H'<]]'?:-N<"JS@(:(8X!&>+>A"JHCQQ=,'8%M-[\LQ%%SY-
MF6MJ;"9-6.J:H!BQ& /1*+2H$'LBXA];><9.!-WW0M%2NN8"L&JB8<B"HL/N
M#02DDOME9"DP2Q,U@/5"TI8Z/]T S+9./0Q=4)P YN!3DDKOEY3%(Z%4W0_
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MNEW<4[D['I<]E4:'])J"T'"@Y)O/L(X2E*LT=;C,ZL\-EZP;"T6E'/R,""\
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M92YH=&U02P$"% ,4    " "$2K%6VWPE2DP,  "I1@  '
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M  !G9&,M,C R,S U,39?;&%B+GAM;%!+ 0(4 Q0    ( (1*L5866E.25@<
M -17   4              "  3G6  !G9&,M,C R,S U,39?<')E+GAM;%!+
4!08     "  ( "\"  #!W0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
